Between Real Estate And Science Fiction: Cities Of Immortals – Forbes

The ongoing biotechnology revolution is less discussed than the digital one, but is on par with it, if not more prevalent. While less visible to the everyday eye, progress in healthcare and genetics will dramatically alter the way and where we live. Indeed, it feels like science fiction has crept into reality.

For some time now, it has been possible to create an embryonic precursor from someones blood cells. Essentially, this means that scientists can recreate a younger you in the form of an unevolved and unaged specimen, which could eventually turn into a fetus that will grow into an adult, with your DNA. Some scientists are suggesting that DNA doesnt age much; what does is the epigenetic, or the molecular processes that regulate the expressions of DNA.

Nowadays, a growing scientific movement views aging not as a consequence of growing older, but as a condition in and of itself, a pathology. In other words, aging is a disease that is not a result of a degradation of DNA, but of the epigenetic. Once we understand how to reboot it and restore the functioning of DNA, we could have treatments for aging and perhaps even the possibility to reverse it.

Highly controversial, of course. Nevertheless, we are slowly but surely moving toward dramatically extending human longevity and eventually, towardcellular regeneration (i.e., regrowing limbs).

There are substantial investments being made with this goal in mind, and results will be obtained much faster than we are aware. As an example, in the 1990s, gene therapy was perceived as high-risk and elusive. Today, a group of technologies named CRISPR-Cas9 enables scientists to edit genomes and alter DNA sequences, with the potential to correct genetic diseases and cure cancer.We may even be able to create immortality. Scientists have not yet found how to do it, but at some point, they well could.

Think of the luminaries the world lost early, of diseases or from causes that genetics research seeks to cure. Steve Jobs lived to be 56. He died as Apple just started really growing exponentially in a business sense, and in creativity benefiting from his decades of experience.

Zaha Hadid, the first woman to win the Pritzker prize (considered the Nobel prize for architects) died in 2016 at age 65. She really began to be at the top of her field after 2000, or age 50. Considering that she still might have had her best years ahead, advances in longevity could have an enormously positive effect on our cities, if world-class architects and real estate developers are able to exponentially leverage their experience for longer. Good news.

Urbanism is turning into one of the worlds most pressing issues. Desirable cities are so unaffordable that housing negatively impairs national GDP growth by several points. And well-planned architecture has been found to reduce crime. Boosting longevity could have a direct correlation with much faster economic growth and lower crime. And immortality, all the more. All in all, as human progress accelerates, so should that of our cities and lifestyles.

Living longer would indeed drastically affect the demographic makeup of our cities. With the nationwide trend of migration back toward cities, downtowns have again become gravity centers as jobs, social life and opportunities are all located next to one another. In other words, cities are becoming harder to leave. As their inhabitants have children, grandchildren and great-grandchildren, and live longer, the populations of cities like New York could explode. And so could real estate prices, by the sheer force of supply and demand not to mention that the older the population grows, the higher the amount of savings in the economy, hence additional capital increasing housing prices.

There urgently need to be solutions. Just based on migration trends, nearly 70% of the worlds population will live in cities in 2050. (That number is over 54% today, and was 34% in 1960.)

One solution could be a movement that is already making a comeback in todays world: multigenerational housing, through which several generations of a same family coexist under the same roof. Would the United States then become more like traditional Europe, where close-knit families often live together for decades into adulthood? The potential societal changes are enormous. Cities would, in this case, revert to what they had always been before: homes for whole families, as opposed to, say, downtowns of solely high-earning young professionals.

Additionally, advances in transportation such as ride-sharing will reduce the need to own our own cars. If we need fewer roads, we will have more space to build probably taller, if the aforementioned experts live longer and are able to develop the appropriate real estate structures. There's another factor increasing urban density.

And what about zoning? If we know we will live until 150, will we take a different outlook at community board meetings, and be more open to rezonings to allow the additional housing that enables our family members to stay close to us? Longevity could lead to less friction on hot-button local issues.

The science fiction of longevity and immortality is much closer to reality than we think. It should be embraced, as it features the potential to drastically improve the way we live together. Optimism is de rigueur for one of the planets most challenging and divisive issues. Public policy must follow and allow cities to shape themselves and grow in a way that retains all this means allowing sound, large-scale construction and urbanism.

View original post here:
Between Real Estate And Science Fiction: Cities Of Immortals - Forbes

Start Spring With More Asparagus In Your Cooking – Longevity LIVE

Start Spring off by improving your health with asparagus. This Spring vegetable is not only a tasty seasonal treat. It also has intriguing health benefits. In fact, asparagus will start Spring off by giving you a quick folate boost. It ranks high up in this department along with broccoli and spinach. Better yet, the vegetable contains antioxidants including vitamin C and carotenoids, other vitamins, minerals and fibre. Therefore it is probably one of the most beneficial vegetables.

Interestingly, major studies state that when you eat lots of fruit and vegetables there is a much lower risk of mortality, especially death from cardiovascular disease. On average, each additional serving of fruit and vegetables a day reduced mortality risk by about 5%. But asparagus contains benefits that exceed most vegetables and fruits. It also has compounds that help regulate blood pressure. This might reduce hypertension risk which is a major factor in cardiovascular disease.

Other than its delicious flavor, asparagus can also help fight cancer. Its good for your brain and may even help you slim down. Theres no nutritionally dense vegetable quite like asparagus to start Spring off healthier. Just remember that its best to eat your asparagus as soon as you buy it. Pair it with lots of other spring vegetables and flavors. Were thinking peas, garlic or baby potatoes.

According to research, the health benefits of asparagus extend far. Apparently it can help promote ahealthy pregnancy, improved fertility, relief from the pre-menstrual syndrome, and improved bone health. Moreover, this yummy vegetable may even help you to manage conditions like diabetes, hangovers, cataracts, rheumatism, depression,neurodegenerative diseases, and convulsions. Better yet, it could also reduce the risk of urinary tract infections and blood cholesterol.

It is also brilliant for digestive health and has shown anticancer potential. You dont need to worry about your waistline either because just 1 cup of cooked asparagus contains only40 calories. It also provides you with 4 grams of protein, 4 grams of fiber and 404 milligrams of potassium. We need lots of Potassium in our bodies because it regulates blood pressure. Researchers state that asparagus also contains a compound called asparaptine, which helps improve blood flow and in turn helps lower blood pressure.

Besides tasting amazing, this spring veggie is filled with reasons to enjoy it with your meals. Lets explore some benefits and why you should eat more asparagus.

Start Spring right with this nutrient-packed vegetable. Experts explain that asparagus is an excellent source of fiber, folate, vitamins A, C, E and K, as well as chromium. This is a trace mineral that enhances the ability of insulin to transport glucose from the bloodstream into cells. So if youre trying to keep an eye on your blood sugar then this is great news for you.

For your information, asparagus is part of the herbaceous plant family. This includes avocado, kale and Brussels sprouts. Start Spring with asparagus because its especially rich in glutathione which is a detoxifying compound. This compound can help break down carcinogens and other harmful compounds like free radicals.

Thats why eating asparagus may help protect against and fight certain forms of cancer, such as bone, breast, colon, larynx and lung cancers.

Youll find that asparagus is one of the top-ranked fruits and vegetables for its ability to neutralize cell-damaging free radicals.

This is a great way to start Spring because it could help you slow the aging process and reduce inflammation.

Asparagus is an incredible addition to your cooking because it promotes a healthy brain which is key to living a happy, long life.

This is an integral anti-aging property. If you start spring with this delicious vegetable, you might help assist your brain in fighting cognitive decline. Like leafy greens, asparagus delivers folate, which works with vitamin B12-found in fish, poultry, meat and dairy-to help prevent cognitive impairment.

Moreover, studies using older adults with healthy levels of folate and B12 performed better on a test of response speed and mental flexibility. Therefore, if youre over age-50, then be sure youre getting enough B12. This is because your ability to absorb it decreases with age.

There are more studies demonstrating that asparagus racemosus is effective in reducing the risk of neurodegenerative diseases. Some of which include Alzheimers, Parkinsons, and Huntingtons diseases. Theyve linked these benefits to the presence of phytoestrogens in asparagus which have certain neuroprotective effects. Neurodegenerative diseases are genetic or periodic conditions affecting the neurons of the human brain. The issue is that the body doesnt normally have the ability to replace the damaged neurons.

As you may know, depression is forever increasing around the world. We need to do as much as possible to help alleviate some of its symptoms.

Scientific research is showing the efficacy of asparagus racemosus as an anti-anxiety and anti-depressant drug. You see, now you can also help start Spring off on a happier note. Asparagus may even help enhance memory, increase the production and secretion of estrogen, and revitalize and calm the nervous system. A pretty amazing way to start Spring, right?

Asparagus contains high amounts of a nutrient called inulin. This is a kind of complex carbohydrate, commonly known as prebiotic.It does not get digested until it reaches the large intestine, where it is fed upon by a kind of good bacteria like lactobacilli. Inulin aids in the improved absorption of nutrients.

Start Spring with asparagus because it is also packed with high levels of the amino acid asparagine. This acts as a natural diuretic. Increased urination not only releases fluid but helps rid the body of excess salt. This is especially beneficial for people who suffer from edema (an accumulation of fluids in the bodys tissues) and those who have high blood pressure or other heart-related diseases.

You might also be wondering why eating asparagus causes a strong urinary odor. Well, experts explain that asparagus contains a unique compound that, when metabolized, gives off a distinctive smell in the urine. Young asparagus contains higher concentrations of the compound so the odor is stronger after eating it.

Fortunately, there are no harmful effects, either from the sulfuric compounds or the odor. So you can happily start Spring by cooking with more asparagus!

When shopping the most common type of asparagus is green. However, you might find two others in supermarkets and restaurants: white, which is more delicate and difficult to harvest, and purple, which is smaller and fruitier in flavor. No matter the type you choose start Spring with this vegetable. Asparagus is a delicious, versatile vegetable that can be cooked in a variety of ways or enjoyed raw in salads.

A hectic lifestyle and poor diet affect the number of essential nutrients taken on a daily basis. Heres why eating good foodis the best way to get the right balance of vitamins and minerals.

5 Powerful Health Benefits of Asparagus You Probably Didnt Know. Eating Well. http://www.eatingwell.com/article/17129/5-powerful-health-benefits-of-asparagus-you-probably-didnt-know/

17 Impressive Benefits Of Asparagus. Organic Facts. https://www.organicfacts.net/health-benefits/vegetable/health-benefits-of-asparagus.html

Cancer: Treatments & Home Remedies. Organic Facts. https://www.organicfacts.net/home-remedies/home-remedies-for-cancer.html

Whats New And Beneficial About Asparagus? The Worlds Healthiest Foods. http://www.whfoods.com/genpage.php?tname=foodspice&dbid=12

The Unique Health Benefits Of Asparagus. Noted. https://www.noted.co.nz/health/health-nutrition/asparagus-the-unique-health-benefits

Read this article:
Start Spring With More Asparagus In Your Cooking - Longevity LIVE

Longevity And Anti-Senescence Therapy Market Overview, Consumption, Supply, Demand & Insights – Kentucky Journal 24

The global longevity and anti-senescence therapies market should grow from $329.8 million in 2018 to $644.4 million by 2023 with a compound annual growth rate (CAGR) of 14.3% during 2018-2023.

Report Scope:

The scope of this report is broad and covers various therapies currently under trials in the global longevity and anti-senescence therapy market. The market estimation has been performed with consideration for revenue generation in the forecast years 2018-2023 after the expected availability of products in the market by 2023. The global longevity and anti-senescence therapy market has been segmented by the following therapies: Senolytic drug therapy, Gene therapy, Immunotherapy and Other therapies which includes stem cell-based therapies, etc.

Get Sample Copy Of The Report@https://www.trendsmarketresearch.com/report/sample/11698

Revenue forecasts from 2028 to 2023 are given for each therapy and application, with estimated values derived from the expected revenue generation in the first year of launch.

The report also includes a discussion of the major players performing research or the potential players across each regional longevity and anti-senescence therapy market. Further, it explains the major drivers and regional dynamics of the global longevity and anti-senescence therapy market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market.

Report Includes:

71 data tables and 40 additional tables An overview of the global longevity and anti-senescence therapy market Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023 Country specific data and analysis for the United States, Canada, Japan, China, India, U.K., France, Germany, Spain, Australia, Middle East and Africa Detailed description of various anti-senescence therapies, such as senolytic drug therapy, gene therapy, immunotherapy and other stem cell therapies, and their influence in slowing down aging or reverse aging process Coverage of various therapeutic drugs, devices and technologies and information on compounds used for the development of anti-ageing therapeutics A look at the clinical trials and expected launch of anti-senescence products Detailed profiles of the market leading companies and potential entrants in the global longevity and anti-senescence therapy market, including AgeX Therapeutics, CohBar Inc., PowerVision Inc., T.A. Sciences and Unity Biotechnology

Request For Report Discount@https://www.trendsmarketresearch.com/report/discount/11698

Summary

Global longevity and anti-senescence therapy market deals in the adoption of different therapies and treatment options used to extend human longevity and lifespan. Human longevity is typically used to describe the length of an individuals lifetime and is sometimes used as a synonym for life expectancy in the demography. Anti-senescence is the process by which cells stop dividing irreversibly and enter a stage of permanent growth arrest, eliminating cell death. Anti-senescence therapy is used in the treatment of senescence induced through unrepaired DNA damage or other cellular stresses.

Global longevity and anti-senescence market will witness rapid growth over the forecast period (2018-2023) owing to an increasing emphasis on Stem Cell Research and an increasing demand for cell-based assays in research and development.

An increasing geriatric population across the globe and a rising awareness of antiaging products among generation Y and later generations are the major factors expected to promote the growth of global longevity and anti-senescence market. Factors such as a surging level of disposable income and increasing advancements in anti-senescence technologies are also providing traction to the global longevity and anti-senescence market growth over the forecast period (2018-2023).

According to the National Institutes of Health (NIH), the total geriatric population across the globe in 2016 was over REDACTED. By 2022, the global geriatric population (65 years and above) is anticipated to reach over REDACTED. An increasing geriatric population across the globe will generate huge growth prospectus to the market.

Senolytics, placenta stem cells and blood transfusions are some of the hot technologies picking up pace in the longevity and anti-anti-senescence market. Companies and start-ups across the globe such as Unity Biotechnology, Human Longevity Inc., Calico Life Sciences, Acorda Therapeutics, etc. are working extensively in this field for the extension of human longevity by focusing on study of genomics, microbiome, bioinformatics and stem cell therapies, etc. These factors are poised to drive market growth over the forecast period.

Global longevity and anti-senescence market is projected to rise at a CAGR of REDACTED during the forecast period of 2018 through 2023. In 2023, total revenues are expected to reach REDACTED, registering REDACTED in growth from REDACTED in 2018.

The report provides analysis based on each market segment including therapies and application. The therapies segment is further sub-segmented into Senolytic drug therapy, Gene therapy, Immunotherapy and Others. Senolytic drug therapy held the largest market revenue share of REDACTED in 2017. By 2023, total revenue from senolytic drug therapy is expected to reach REDACTED. Gene therapy segment is estimated to rise at the highest CAGR of REDACTED till 2023. The fastest growth of the gene therapy segment is due to the Large investments in genomics. For Instance; The National Human Genome Research Institute (U.S.) had a budget grant of REDACTED for REDACTED research projects in 2015, thus increasing funding to REDACTED for approximately REDACTED projects in 2016.

Report Analysis@https://www.trendsmarketresearch.com/report/analysis/BCC/global-longevity-and-anti-senescence-therapy-market

View post:
Longevity And Anti-Senescence Therapy Market Overview, Consumption, Supply, Demand & Insights - Kentucky Journal 24

Montana: the grayest state in the West – Montana Free Press

By Eric Dietrich and Brad Tyer | March 12, 2020

Graying Pains: Challenges and Opportunities in the Wests Oldest State is a six-month series of weekly stories and broadcasts exploring the economic, cultural, and personal impacts of Montanas aging demographics. The series is coordinated by Montana Free Press and produced by The Montana Fourth Estate Project, a collaboration among 15 Montana newspapers, Yellowstone Public Radio, and the University of Montana School of Journalism.

For our publishing partners: This article is subject to reprint restrictions as detailed here. This story may not be republished prior to Thursday, March 26, 2020.

People have been parsing the human lifespan into a taxonomy of ages forever. Aristotle proposed three categories: youthful, prime of life, and elderly. Two thousand years later, Shakespeares Seven Ages of Man carved human chronology into seven slices, with the bodys final frailty circling back to the original oblivion of infancy. And in the 1980s, British historian Peter Laslett proposed a revised map of three ages, with a caveat for the third: it could be a time of post-retirement fulfillment and achievement, or it could collapse, a la Shakespeare, into dependence and decrepitude.

The character of any individuals third age hinges on some key factors, including health, wealth, community, and the government policies and cultural customs that influence them. Navigating those factors requires independence, assistance, access, and education. The latter, especially, is lacking. Missoula Aging Services Executive Director Susan Kohler told a room full of Montana journalists in November that one of the biggest impediments to a fulfilling third age is lack of preparedness.

GET READY

Already, Montana is the oldest state west of the Mississippi, according to median age statistics from the U.S. Census Bureau. With half the states population 40 or older, were the 9th oldest in the nation, out-grayed only by Florida, Maine, and a few other eastern states.

Peak age is yet to come, according to demographic projections produced for the state Department of Commerce by consulting firm REMI. As of 2017, the baseline year used by those projections, 18% of Montanans were 65 or older, up from 14% in 2001. The figure is expected to climb to 22% by 2030 then plateau through 2040 as boomers reach the end of their lives.

Different parts of the state, however, are on very different trajectories. Sparsely populated rural counties tend to have higher percentages of seniorsand are, in many cases, on track to become even more disproportionately older. Petroleum Countys 520 residents make it the lowest-population county in Montana, and by 2030, 37% of county residents will be past retirement age,up from 23% in 2017. For Teton County, northwest of Great Falls, the 2030 figure is projected to be 27%, up from 22%.

Population centers like the Billings area tend to trend closer to the state as a whole, age-wise, though college towns Missoula and Bozeman are substantially younger than other urban areas, and are expected to stay that way. Seniors 65 and over accounted for 16% of the population of Yellowstone County (including Billings) and 12% of the population of Gallatin County (including Bozeman) in 2017. Those figures are projected to rise to 21% and 15%, respectively, by 2030.

Counties with sizable Native American populations, such as Roosevelt County (including Wolf Point), Big Horn County (including Hardin and Crow Agency), and Glacier County (including Cut Bank and Browning) are also younger than neighboring rural areas. Roosevelt County, with only 11% of its population over 65, is the states youngest by that measure.

WHY THE STATE IS AGING

Driving those trends are three key demographic forces: birth, death, and migration. Higher birth rates pull areas younger while longer lifespans populate communities with more elders. Migration, in turn, tends to siphon young, mobile residents away from some places and toward others.

Montanas population is skewing older,in part, as the oversized generation of baby boomers born in the aftermath of World War II, between 1946 to 1964, reaches retirement age. According to the U.S. Census Bureau, longer life expectancies and declining birth rates are also a factor thats aging American communities across the nation. While average life expectancy in the U.S. was 68.2 in 1950, according to the National Center for Health Statistics, it was a decade longer, 78.6, in 2017.

In Montana, the median age of death is now 75 for men and 82 for women, according to the state Department of Public Health and Human Services. Montanas Native communities are younger in part because death typically comes much earlier for American Indian Montanans, with DPHHS reporting a median age of death at 60 for Native men and 63 for Native women.

Counties with larger Native populations also tend to have higher birth rates, which means more young residents. For example, Roosevelt County, which is 57% Native, saw a rate of 22.3 births per 1,000 residents annually between 2010 and 2018, according to a Montana Free Press analysis of census data. The equivalent figure for Yellowstone County, in comparison, was 13.2.

Migration rounds out the picture. While Montana attracts some older migrants looking for a change of scenery in retirement, migration is on the balance a youthening force for destination communities, because young people constitute the lions share of movers. According to census estimates based on surveys conducted between 2014 and 2018, 58% of Montanas new arrivals to Montana are under the age of 30, versus just 11% who are 60 or older.

As such, migration patterns also contribute to the graying of places where there arent enough new arrivals to balance the number of young people moving away for school or work, creating the brain drain dynamic that has posed a challenge for swaths of rural Montana for decades.

WHAT IT MEANS FOR MONTANA

Those trends create challenges.

At a community level, an older population means more demand for health care services. A 2012 study by economists at Montana State University, for example, estimated that the states aging demographics would necessitate increased state Medicaid spending. And with large portions of the health care system funded by the state-administered Medicaid program, aging creates public policy questions at the state government level as well.

At the same time, an aging population is predicted to diminish the proportion of states residents who are in the workforce and available to staff nursing jobs,not to mention other businesses. Montanas working-age population of residents between the ages of 15 and 64 was 64% of the populace as of 2017. While the total number of working-age Montanans is projected to increase with population growth, the working-age share of the population is expected to decrease slightly, to 60%, by 2030.

That study also concluded that the aging of Montana will produce a modest shift in state revenue sources away from income taxes, which are highest for workers in the peak of their careers, and toward property taxes, which are higher for older adults, including retirees, who tend to live in more valuable homes than younger residents.

WHAT IT MEANS FOR YOU

An aging population doesnt just influence tax projections and hospital budgets and worker supply.

It affects family farming and Elks Clubs.

It affects churches and nonprofits and all manner of governmental safety nets, whose funding structures are already strained.

It affects the aging and the aged, many of whom face financial insecurity and isolation. And it affects the generations behind them, who are increasingly called on to care for elderly parents, even as many raise their own children, who may one day help care for them.

The average American life expectancy has increased by three decades over the course of the 20th century, contributing to the aging of America and suggesting the need for what a 2018 Stanford Center on Longevity initiative calls a new map of life that reimagines education, work, retirement, intergenerational relationships, financial planning, and health care to support a society in which more of us than ever are living in Lasletts third age.

Montana is on the forefront of that national trend, giving Montanans an opportunity to, as Center on Longevity Director Laura Carstensen wrote in the Washington Post, redesign how we live.

See the rest here:
Montana: the grayest state in the West - Montana Free Press

Coronavirus: What does a COVID-19 recovery mean for you – Gulf News

Philippines, Mar 10: Passengers wear protective masks inside a crowded train following new cases of coronavirus in Manila. Image Credit: ANI

Dubai: As people across the globe look at the growing number of COVID-19 cases, now over 116,000, and the death toll of over 4,091, one key figure is being ignored - the recovery rate.

On Tuesday, China reported that a whopping 70 per cent of coronavirus cases in the country had'recovered'.

The total global number of recoveries, at the time of publishing, stands at 64,750 with 60,113 recoveries in China alone. Iran, the worst affected in the region, reported 2,731 recoveries.

recoveries out of over 116,000 coronavirus cases worldwide

In Macao, all 10 cases reported recovered, showcasing a 100 per cent recovery rate as of March 10. Sri Lanka, Gibraltar and Nepal also reported 100 per cent recovery - one case reported and recovered for each.

China

In China, recent days have seen more recoveries than new cases.Chinese President Xi Jinping visited the coronavirus epicenter of Wuhan for the first time since the disease emerged, state media said, a trip intended to project confidence that his government has managed to stem its spread domestically.

Xi arrived Tuesday morning in the capital of hard-hit Hubei province, the official Xinhua News Agency said. Wuhan, where the disease first emerged in December, has been quarantined since January 23.

What does a COVID-19 infection look like

In most cases, a person with COVID-19 or coronavirus infection has a fever which then goes away without specific treatment. This progression is called a 'mild case' and the World Health Organization reported thatnearly80 percent of all COVID-19 cases are mild.

Most involve fever, dry cough and, in some cases, shortness of breath. People with mild cases are expected to recover without any issues, and in many cases they may not be aware they're ever sick.

A report in the Journal of the American Medical Association (JAMA) studied the COVID-19 infection in 138 patients in Wuhanand came up with the most common progression seen in cases. 99 per cent of the cases surveyed,all of whom were hospitalised at Zhongnan Hospital of Wuhan University during January had fever as a recorded symptom. Dry cough and fatigue were also common symptoms.Patients who developed complications did so within five days after they first started having the symptoms.

In the cases that do get worse, pneumonia is a common ailment which then could lead to further organ dysfunction.

What aids in the recovery?

The new coronavirus has no vaccine or cure yet, but what can be attributed to the 70 per cent recovery rate then?

Nothing in particular yet, studies and accounts show, except the humanimmune system. Many people who recovered had mild symptoms to begin with and did not develop further complications.

She initially tested negative for the virus on her return to India from Wuhan (January 24) but later developed symptoms. The student, who preferred to withhold her name and details, said she put herself in home-quarantine despite testing negative and having no symptoms. She got her temperature recordedregularly before getting a sore throat and she alerted her local government facility (January 27).

Despite no fever at the time, she was put on antibiotics and kept in quarantinewhile tests were done. In 48 hours her test came back positive (January 30), by which she also had a fever.The student prescribed anti-viral drugs,Oseltamivir IP 75 mg also known by the brand name Tamiflu, for five days.

She said, "I had no diet restrictions or anything. I continued in quarantine until February 20 and was tested every alternate day. A blood, urine, stool sample and nasal or throat swab was taken and samples sent to the NIV Pune. After testing negative for nearly a week I was declared free of COVID-19 and have returned home, resumed normal life."

None of her family members or friends contracted the virus from her, she said, as she had put herself in quarantine and followed necessary protocol.

From the time she tested positive, according to her account, it was 14 days before she started testing negative for nearly one week and being declared free of the virus.

Not every recovery story is the same

In Italy, a 38-year-old man named Mattia - who is believed to be patient one in the Lombardy area - was moved out of the intensive care unit and is on the way to recovery, authorities reported on Tuesday.

At the San Matteo hospital in Pavia, there was a sigh of relief after Mattia began breathing on his own Monday with just a small amount of oxygen assistance, said Dr. Francesco Mojoli, head of intensive care. He was moved out of the ICU to a sub-ICU unit and was speaking with doctors.

"This disease has a long life,'' Mojoli told RAI state television. "Now we hope that the fact that he was young and in good shape will help him get back to his normal life.''

Mattia first went to the hospital in Codogno on February18 complaining of flu-like symptoms. He was sent home but came back the next day after his condition worsened dramatically. He was only tested for coronavirus after doctors learned that in early February he had met with a man who had been to China.

By then, however, he had infected his wife and several doctors, nurses and patients at the Codogno hospital, creating what was thought initially to have been Italy's main cluster.

This case is an example of a case that went well over the 14-day mark due to complications and a lack of awareness. In most cases, however, 14 to 20 days is considered standard for monitoring symptoms and getting a conclusive positive/negative test.

The best route to recovery

As seen from many cases worldwide, the best way prevent infectionis basic hygiene and following quarantine protocols when necessary. The best route to recovery is to depend on one's own immune system.

Following the first reported recovery in the UAE,Gulf News spoke to a specialist in internal medicine, Dr Smitha Muraletharan, from Aster Hospital in Al Ghusais, to find out how patients can be cured of coronavirus infection in general.

UAE has reported 17 recovered cases as of March 10.

If you are healthy, you could just pass it off as a cough or cold, Dr Muraletharan told Gulf News. Theres no treatment or cure just support to help your immune system clear it.

Patients with mild to moderate infection when detected early and isolated can get their immune system strong enough to fight the virus, she added.

Risk of getting COVID-19 a second time

Reuters reported that Japan reported its first case who recovered from coronavirus and then became ill with the disease for a second time. This gave way to fears of getting re-infected post recovery and questions regarding the virus's life span.

A small study out of China on four medical professionals who had the virus, published by JAMA, suggests that the new coronavirus can persist in the body for at least two weeks after symptoms of the disease clear up.All of the cases recovered, and only one was hospitalized during the illness.

Recovery is determined if tests for COVID-19 come out negative for two or more consecutive days.The cases studied in Chinacontinued to get throat swabs for the coronavirus after five days for up to 13 days post-recovery - which showed positive.

"These findings suggest that at least a proportion of recovered patients still may be virus carriers," the study concludes.

It is not uncommon for a virus to live on in the human body despite 'recovery'. Viruses such as the Zika virus, Ebola etc. tend to live on in recovered patients for months. The mono virus or the Epstein-Barr Virus can exist in the body for an entire lifespan, in most cases staying dormant and without any issues. The virus that causes chicken pox, for example, remains in your nerve tissues after infection in a dormant state.

Immunity against coronavirus

The human body's response to viruses is what is called 'immunity' where antibodies are created to recognise and destroy viruses. The reason most people are immune to chicken pox post an infection is because of the antibodies created to respond to that particular virus -varicella zoster virus - which is still in the human system but is dormant. In another example, when testing recovered cases from the 1918 Spanish flu in a 2008 paper published in Nature science journal, 90 per cent of survivors still had a high concentration of antibodies against that specific virus strain.

In the coronavirus infection, the immune system is able to create antibodies as it does with all viruses which is what ultimately results in recovery. However, factors such as the strength and longevity ofthese antibodies along with the mutation pattern of the virus could lead to possible relapse.

- Krys Johnson, an epidemiologist at Temple University's College of Public Health

In the case of the Japanese woman who got sick again post a COVID-19 recovery, experts have various opinions.

The efficacy of antibodies created and the longevity of these is one angle.

Zhan Qingyuan, director of pneumonia prevention and treatment at the China-Japan Friendship Hospital, had warned that this could happen. "For those patients who have been cured, there is a likelihood of a relapse," Zhan said in a press briefing on January 31. "The antibody will be generated; however, in certain individuals, the antibody cannot last that long."

In another angle, experts suggested dormancy of the virus andlater exacerbation.

Once you have the infection, it could remain dormant and with minimal symptoms, and then you can get an exacerbation if it finds its way into the lungs, Philip Tierno Jr., Professor of Microbiology and Pathology at NYU School of Medicine told Reuters.

Yet another angle is the mutation rate of the new coronavirus which is unknown as of now.

Krys Johnson, an epidemiologist at Temple University's College of Public Health told Live Science that viruses that stay behind in dormant states have a low chance of re-infection.

However, he added, there is always the possibility that the new coronavirus would mutate as it moves through populations, changing into a version that already-exposed immune systems can't recognize.

"The challenge is, how fast does this mutate?" Johnson said.

Testing for re-infection, recovery: Methods

There are many tests being researched as the best way to determine the presence of the virus. Some are very sensitive while others are not as sensitive in possibly dormant cases.

The study of the four Chinese medics with COVID-19, for example, showed positive results days after recovery from symptoms in a highly sensitive test that amplifies even the smallest viral molecule - the RT-PCR test (Reverse Transcription Polymerase Chain Reaction). This test studies RNA and DNA to analyse the presence of the virus.

In a paper published on February 26 in the Radiological Society of North America, it was found that a chest CT scan has a high sensitivity for diagnosis of COVID-19 and that it could be used as a primary tool for the current COVID-19 detection in epidemic areas.

As of now, the most common and easily accessible method of testing is the throat swab which is widely used in airports, hospitals and other quarantine facilities globally. TheCentre for Disease Control (CDC) recommends four swabs daily to determine recovery.

What does a recovery mean?

When the viral load or concentration goes down in a person, so much so that his immune system is able to fight back symptoms, his throat swabs start showing low or no evidence of the COVID-19 virus. This usually happens in a span of 15-21 days. The patient is tested every alternative day until his swabs test negative for the virus. Under such circumstances the patient is said to have recovered from COVID-19.

Explaining the process, Dr Mohammad Rafique, Medical Director of Prime Hospital, Head of Infection Control and specialist pulmonologist said recovery from COVID-19 infection did not mean one was completely virus free but the virus load had become lower and the bodys immune system had created antibodies to fight back.

Dr Mohammad Rafique

In general from studies conducted on patients one has learnt that the virus presents mild to moderate symptoms with headache, fever and cough, gastro-intestinal symptoms and so on, in younger people. Only those above 60 and with co-morbidities have severity and fatality. What makes it contagious is its high shedding rate. But when kept in isolation and with symptomatic treatment in many cases with double dose of anti-virals, the load of the virus comes down.

Dr Rafiqe added that simple Polymerase Chain Reactor tests (PCR) records the ability of the virus to replicate. When the PCR rates fall and the virus is present in very low copies it does not show in the assay. Naso-pharyngeal and throat swabs are taken every 24 hours and when these turn up negative, a person is said to have recovered. It means that the virus load is so low that it does not show up in the swab tests. That is when a persons immune system has be activated creating enough anti-bodies to combat it and he or she is said to have recovered.

Dr Satyam Parmar, head of Pathology at RAK Hospital explained : As per the guidelines of the Centre for Disease Control, four swabs, in 24 hours gaps are taken totally from the nasopharyngeal and throat area to check if the patient has recovered.

Dr Satyam Parmar

"When all of these turn negative only then is patient declared to have recovered from COVID-19. it is advisable that a patient who has recovered must still continue to be in isolation for four to five days as his immune system has developed antibodies but the virus might still be lurking in small numbers.. This is what happens in other strains of coronavirus such as MERS and SARS, explained Dr Parmar.

*All numbers and toll taken fromhttps://www.worldometers.info/coronavirus/ as of 6pm onMarch 10.

Link:
Coronavirus: What does a COVID-19 recovery mean for you - Gulf News

The Fight against Socialism Isnt Over – National Review

Sen. Bernie Sanders addresses a news conference in Burlington, Vt., March 11, 2020. (Lucas Jackson/Reuters)Bernie Sanders isnt a relic. Hes a preview of things to come.

Democrats are breathing a sigh of relief. Joe Bidens victories on Mini Tuesday make his delegate lead all but insurmountable. Bernie Sanderss electoral weakness, compared with his performance four years ago, has dulled the fear of an incipient socialist takeover of the worlds oldest political party. The left is said to have talked itself into believing its own propaganda and helped President Trump equate Democrats with socialism. Victory in the primary did not come from pledges to eliminate private health insurance or impose wealth taxes. It followed from the perception that Biden is the candidate best able to defeat Trump.

Dont write off the socialist revival just yet. Sanders might not win the Democratic nomination. But this outcome does not mean the forces that propelled him to second-place finishes in the two most recent Democratic primaries will vanish overnight. Abandoning the intellectual fight against socialism, both inside and outside the Democratic Party, would cede the field to an increasingly sophisticated and networked band of ideological activists whose influence in media and politics is greater than their numbers. Such ambivalence could have devastating consequences for American society.

The resurgent left has pushed Biden far beyond where he stood as vice president. And a socialist infrastructure guarantees the philosophys longevity. Aspiring Democratic politicians must at least deal with, if not pay obeisance to, groups such as the Working Families Party and the Democratic Socialists of America. Especially if they inhabit a deep-blue district ripe for picking by the Squad.

Fashionable, lively, radical, and controversial outlets, including Jacobin, Current Affairs, the Young Turks, Chapo Trap House, and Secular Talk, complement popular Instagram and Twitter accounts. And the New York Times magazines 1619 Project shows that the mainstream media is responsive to, and willing to participate in, the latest trends in anti-Americanism.

The most obvious reason not to dismiss the Sanders phenomenon is demographic. On Super Tuesday, Sanders won 30- to 44-year-olds by 18 points, and 18- to 29-year-olds by a staggering 43 points. He defeated Biden by nine points among Hispanic voters and by 25 points among Asian voters. Asian Americans are the fastest-growing ethnic group in the country. Hispanics are second. Sanderss protege, Alexandria Ocasio-Cortez, a 30-year-old woman of Puerto Rican descent, represents this ethno-generational cohort. Their place in American life will not be denied.

Right now, socialism is unpopular. Last month, only 45 percent of adults told Gallup they would vote for a socialist for president. Last year, a 51-percent majority said socialism would be a bad thing for the United States. But Gallup also found that the number who said socialism would be a good thing had risen to 43 percent in 2019 from 25 percent in 1942. A majority of Democrats have held positive views of socialism since 2010. A willingness to adopt the socialist ideal is most pronounced among the young. A YouGov poll conducted last year for the Victims of Communism Memorial Foundation found that 70 percent of Millennials are either somewhat or extremely likely to vote for a socialist.

It is the decline in institutional religion that drives the resurgence of socialism. Gallup found that church membership among U.S. adults has dropped precipitously over the last two decades, to 50 percent in 2018 from 70 percent in 1998. Why? Because the percentage of adults who profess no religious affiliation has more than doubled. It has gone to 19 percent from 8 percent. The Millennials exhibit the lowest percentage of church membership among generations. Pew says the number of Americans who identify as Christians fell more than ten points over the last decade as the number of religiously unaffiliated spiked. Here too the largest falloff was among Millennials.

Religion not only offers answers to the most powerful, definitive, and ultimate questions of human existence and purpose. It anchors individuals in a particular authoritative tradition defined by doctrinal orthodoxy and refined through multigenerational practice. People released from these bonds are capable of believing anything. Thus, socialism has returned at the same time as climate apocalypticism, transhuman and transgender ideology, anti-vaccination movements, anti-Semitism, conspiracies, and ethnonationalism. In this climate of relativism and revisionism, where the most outlandish theories are a Google search away, both Marxism and utopian socialism seem credible. Nothing is too absurd.

Irving Kristol said that it is easy to point out how silly and counterproductive and even deadly socialism has been, in so many respects, but difficult to recognize its pull as an emotional attachment. The love of equality and progress makes for a special and durable political passion. Socialism, wrote Irving Howe in 1954, is the name of our desire. In the absence of an intellectually coherent and morally compelling account of the inequalities inherent to liberal democracy, so will the desire remain.

This piece originally appeared on the Washington Free Beacon.

Read the original here:
The Fight against Socialism Isnt Over - National Review

AgeX Therapeutics Researchers Publish Paper on the Age Reprogramming of Super-Centenarian Cells – Business Wire

ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (AgeX; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced a new paper co-authored by two AgeX scientists that could lead to new insights into the fundamental mechanisms of aging and why super-centenarians not only live the longest, but also experience extraordinary healthspans; an extension of the healthy years of life that compresses morbidity to a very short period near the end of life. The paper, Induced pluripotency and spontaneous reversal of cellular aging in supercentenarian donor cells, is published online in the peer-reviewed scientific journal Biochemical and Biophysical Research Communications from Elsevier. The senior author is Dana Larocca, PhD, VP of Discovery Research at AgeX, and the first author is Jieun Lee, PhD, Scientist at AgeX.

Clearly, we can learn a lot about aging and longevity from the longest of the long-lived, the supercentenarians, and we hope that this paper accelerates such research, commented Dr. Larocca. Now that we have converted the cells of one of the longest-lived people in history, a deceased 114-year-old American woman, to a young pluripotent state, researchers can do so with cells from other supercentenarians. The goal is to understand specifically how these extreme agers manage to avoid the major chronic illnesses of aging better than any other age group including centenarians. We can essentially put their cells in a time machine and revert them to an earlier state, then study their biology to help unlock the mysteries of super-longevity. Scientists have long wondered, and now we know that we can indeed reset the developmental state and cellular age in the oldest of the old.

By way of comparison, the paper also describes undertaking a similar process with cells from two other donors: an eight-year-old with a rapid-aging syndrome commonly known as Progeria, and a 43-year-old, healthy disease-free control (HDC) subject. The paper notes that the supercentenarians cells reverted to induced pluripotent stem (iPS) cells at the same rate as the HDC subject and the Progeria patient. However, there may be some negative impact of extreme age on telomere resetting as this did not occur as frequently in the supercentenarian as in the other two donors.

The donated cells were from the longevity collection, a cell bank established by the NIHs National Institute on Aging.

About AgeX Therapeutics

AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics for human aging. Its PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly-defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeXs revolutionary longevity platform induced Tissue Regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. AGEX-iTR1547 is an iTR-based formulation in preclinical development. HyStem is AgeXs delivery technology to stably engraft PureStem cell therapies in the body. AgeX is developing its core product pipeline for use in the clinic to extend human healthspan and is seeking opportunities to establish licensing and collaboration agreements around its broad IP estate and proprietary technology platforms.

For more information, please visit http://www.agexinc.com or connect with the company on Twitter, LinkedIn, Facebook, and YouTube.

Forward-Looking Statements

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not historical fact including, but not limited to statements that contain words such as will, believes, plans, anticipates, expects, estimates should also be considered forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of AgeX Therapeutics, Inc. and its subsidiaries particularly those mentioned in the cautionary statements found in more detail in the Risk Factors section of AgeXs Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commissions (copies of which may be obtained at http://www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. AgeX specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

See the original post:
AgeX Therapeutics Researchers Publish Paper on the Age Reprogramming of Super-Centenarian Cells - Business Wire

A Conversation With a Harvard Geneticist on How to Live (Well) Past 100 – InsideHook

In Parks and Rec, Rob Lowes Chris Traeger is a perennially positive, supplement-popping 45-year-old who glides through the rooms of Pawnee City Hall with golden retriever energy. He brings vegetable loaves to birthday parties, regularly runs 10 miles during his lunch breaks and touts just 2.8% body fat. In Season 2 of the show, Traeger reveals his lifes goal: to live to 150.

Scientists believe that the first human being to live to a 150 years has already been born I believe I am that human being. At first, it sounds like just another quotable line from a show thats famous for them. Traeger isnt to be taken seriously, after all. One of his other signature adages is simply Stop pooping. (On the exceedingly rare occasions that Traegers body fails him, he lands in a dark place.)

Believe it or not, though, Traegers right. At least one scientist has been predicting humankinds potential to live to 150 for the better part of a decade, a man whos furthered the notion of aging as disease since he arrived at MIT in the late 1990s. That would be Australian Dr. David Sinclair, a biology rockstar and former Time 100 honoree with an Order of Australia (Down Unders version of knighthood), and his own genetics lab at Harvard Medical School.

In September of last year, Dr. Sinclair released Lifespan: Why We Age and Why We Dont Have To. Its an explosive call to arms detailing Dr. Sinclairs core belief, which hes spent decades researching: most humans leave decades of high-quality life on the table simply because society doesnt afford aging the same attention and dollars it reserves for other health crises like cancer and heart disease. The book is one part memoir (Dr. Sinclair recalls the drawn-out final decades of his mother and grandmothers lives), one part crash-course in epigenetics (we hold far more in common with yeast cells than the common person knows) and one part sneak peek into the advancements being made in the worlds preeminent genetics labs (Dr. Sinclairs team has successfully cured blindness in mice).

Most refreshingly, though, Lifespan delights in giving answers. On top of the many science-fiction-esque wonders on display at Harvard Medical School each week (Dr. Sinclair is a pioneer of a practice called cellular programming, which effectively means resetting cells back to a younger age), the book includes functional day-to-day advice on how the layman or woman can activate survival processes in their epigenome, engaging specific sirtuin proteins (a class of protein that helps regulate cellular aging) to help foster greater longevity.

Basically, Sinclairs hypothesis is that eating a certain way, working out a certain way and exposure to a certain kind of temperature can make living past 100 a relative breeze. We recently caught up with Dr. Sinclair to discuss his book, intermittent fasting, Benjamin Button and more.

InsideHook: This book definitely doesnt mince concepts or words. Why was it important to you to write so boldly on aging as a disease?

Dr. David A. Sinclair: The world is in a stupor when it comes to aging. Theres a blind spot. I wrote the book to shake things up, and hopefully wake up those who dont think aging is important or worth working on. We focus as a society far too much on the end consequence of aging, playing whack-a-mole with these diseases that kill us. We ignore whats actually driving these diseases. The more we study aging, though, the more we realize that the diseases we treat are all manifestations of an underlying process. And its treatable.

Some of your peers in the field have said it isnt a good look to be so declarative in your predictions on aging. Have they changed their tune since the book was released?

I havent had any criticism from colleagues since the book came out. Either they havent read it, or theyre okay with my arguments. But also, the world is changing. What used to be considered crazy 10 years ago is no longer crazy. For example, scientists didnt used to say the phrase reversal of aging. But now, its a fact thats doable. Our field has proven that many aspects of aging are reversible, including blindness. Its also partly that I was ahead of the curve, and that things which were once forbidden are now in the realm of discussion and debate.

Im fascinated by the cellular reprogramming work your lab has done. In the book, you invoke F. Scott Fitzgeralds Benjamin Button story to describe how a 50-year-old could soon begin a routine that will have him/her feeling and looking 30 again. Are we actually close to seeing that sort of treatment in the developed world?

The first thing to say is we now understand that changes in your lifestyle can dramatically improve your age and physiology. We used to think that aging was just something that was in our genes, something that we couldnt modify. But very rapidly, within months of changing diet and exercise, you can reverse many aspects of aging. Its never too late, unless youre on your last legs. The fact that its that easy to slow down and reverse aspects of aging just with lifestyle changes totally fits with our understanding of molecular mechanisms. We should be able to slow aging even better with the reprogramming of cells. I see the work weve done as a proof of concept. While its true that Im working hard towards restoring eyesight in people whove lost their vision, its really just the beginning. This work is proof that its possible to restore the age of a complex tissue. In the same way that the Wright brothers werent building rockets to the moon, they could at least imagine that one day it would be possible. Weve shown that there is a backup copy of a youthful epigenome that we can turn on to reset the cell and get it to work again. If thats doable in the eye, it would be rather pessimistic to say we were just lucky to choose the right body part for this to work.

High-intensity training is one of the practices you cite as vital to this process. What about it encourages longevity genes?

Weve found that high-intensity training will induce the sirtuin defenses in the body, similar to what intermittent fasting does. When those genes come on, they defend the cell against diseases, and aging itself. When we dont engage those sirtuin genes, we dont reap the benefits. High-intensity training is particularly good at turning on the sirtuins, because it encourages a hypoxic response, which weve shown leads to the activation of these defense mechanisms. While walking is good, its not as good as doing high-intensity training.

Im glad you mentioned intermittent fasting, another practice you endorse. Are there any mistruths or misunderstandings in the way that popular media portrays it?

Based on recent results in animal studies, its not so much what you eat but when you eat. Of course, you cant eat a hamburger morning, noon and night, then fast the next day and expect to get the maximum benefits. That said, it seems to be more about just having a period of fasting in general. Theres one misconception that people need an optimal mix of protein, carbohydrates and fat, and that thats the most important thing to get right. Id say worry about that less, as long as youre getting nutrients and xenohormetic molecules, which are molecules produced by plants when theyre under stress. As long as youre doing those things, its far more important to skip meals.

One other thing: people claim that there is an optimal intermittent fasting protocol. The truth is, we dont know what the optimal is. Were still learning, and its individual. There are individual differences in all of us. There is a subset of people, myself included, who start producing glucose out of their livers early in the morning, at around 6 a.m. Which means, for me, to start eating breakfast around 7 a.m. makes no sense. Some people, though, have such low blood sugar in the morning that they can barely function. We also dont know the best method. Is it the 16/8 [hours, first on and then off of the fast]? Two days fasting out of every five? We really dont know yet. But we do know that if youre never hungry, if youre eating three meals a day and snacking in between, thats the worst thing you can do. It switches off your bodys defenses. Some fasting is better than none.

Do you eat meat?

I do, but its a gradient. Its mostly plants, then fish, rarely chicken, and almost never red meat.

From an aging perspective, do you recommend that people give up meat?

For the average person, focus on plants. Meat isnt going to kill you if you eat it once in a while, but the reason for the plant-based diet is we know where the hot spots are for longevity. We know what theyre eating. Its not a mystery. Theyre not carnivores. Theyre eating mostly plants, and a little bit of meat maybe, a bit of fish. Theyre consuming olive oil, avocados, red wine and other plants that have xenohormetic molecules. I dont think that thats a coincidence.

Theres been some coverage recently about the rise of wild swimming. In the UK, especially, people have started jumping into freezing cold water and claiming all sorts of health benefits. It reminded me of your points in the book about challenging the thermoneutral zone. Does one need to frequently experience extremely cold temperatures to reap benefits?

Cold baths, cryotherapy I was skeptical. I started out skeptical until proven otherwise. But theres some evidence that making brown fat is good. Adult humans can make brown fat as long as theyre not super old, and cold is a good way to do that. One of my favorite genes, the third of the seven sirtuin genes, boosts brown fat. All of these things that were talking about exercise, fasting, cold therapy, even a sauna its best to mix it up. You dont want to be constantly exercising, constantly hungry, or constantly at one temperature or another. You want to shock the body. Putting a few days of recovery in between makes a lot of sense. As for exposing yourself to cold, a little is still better than nothing. I do it once a week. But Im still trying to figure out when to do these ice baths. There was a study that an ice bath after a workout potentially lowers the benefit of the workout.

Lifespan devotes a ton of pages to metformin, the anti-diabetic medication thats been discovered to activate longevity genes. Are there adverse side effects from taking metformin? It seems a little too good to be true.

As far as drugs go, metformin is very safe. The World Health Organization declared it one of the essential medicines for humanity. One in 10,000 people have an adverse side reaction and have to stop taking it. The majority of complaints are attributed to a queasy stomach feeling until you get used to it. I actually dont mind, because it stops me from getting hungry. [Editors note: Dr. Sinclair takes metformin daily.] It doesnt give you anything like a greater risk of cancer or heart disease. The data actually suggests the opposite. The risk of getting old is pretty high, but the risk of taking metformin is pretty low, based on millions of people taking it.

Youre on the record saying the first person to live to 150 has been born. Would that person need to combine every single practice and innovation that you outline in this book in order to do so?

An important point of clarification: I dont think we have any technology today that would get us to 150. But if youre born today, you can be around until the mid-22nd century. Theres a lot thats going to happen between now and then. Were on a path of technological development. Once you see the trajectory and barriers are broken down, it gives me the license to say someone born today will live far longer than we can imagine. People born today will benefit from technologies that come about after were dead. The big breakthrough is being able to reprogram the body. If we can get that to work, wed be literally able to turn the clock back on cells. Weve done it once we managed to restore vision in mice but you might be able to reset cells twice. Or 100 times. Well just have to see.

Related: The Healthiest Blue Zone in Every State, Mapped

Subscribe herefor our free daily newsletter.

See the rest here:
A Conversation With a Harvard Geneticist on How to Live (Well) Past 100 - InsideHook

How do consumer DNA tests from the US and China stack up? – Abacus

Spitting intotheplastic test tube, I felt nervous. I was offering up a piece of myself for decoding, and while this timethere was no silver-haired sage, it reminded me of a visit to a fortune teller when I was 21.

Then, I offeredthepalm of my hand in a bid to divine what fate had planned for me. Now, it wasDNA, with my saliva destined for a laboratory in southwest China, totheheadquarters ofChengdu 23Mofang Biotechnology Co., a startup thats seeking to tap a boom in consumer genetics intheworlds most populous nation.

Rising awareness of genetically-linked diseases like Alzheimers and a natural human curiosity for insight intothefuture is fueling a global market for direct-to-consumerDNAtesting thats predicted totripleoverthenext six years. In China, wherethegovernment has embraced genetics as part of its push to become a scientific superpower,theindustry is expected to see US$405 million in sales by 2022, according to Beijing research firm EO Intelligence, an eight-fold increase from 2018. Some 4 million people will send away test tubes of spit in China this year, and I had just become one ofthem.

Not only was I entering a world where lack of regulation has spawned an entire industry devoted to identifyingthefuture talents of newborn babiesthroughtheir genes, I was handing over my genetic code to a country wherethegovernment has been accused of usingDNAtesting to profile minority groups a concern that hit home whentheresults showed I was a member of one.

I wanted to see whethertheburgeoning industry delivered on its claims in China, where scientists have gained international attention and criticism for pushingtheboundaries of genetics. And as a child of Vietnamese immigrants totheUS, Ive long been curious about my ancestry and genetic makeup.

To get an idea of how this phenomenon is playing out intheworlds two biggest consumer markets, I comparedtheDNAtesting experience of 23Mofang withthefirm CEO Zhou Kun says it was inspired by:23andMe Inc., one ofthebest known consumer genetics outfits intheUS.

PushingtheEnvelope

Thedifferences betweenthetwo companies are stark.

23andMe was co-founded byAnne Wojcicki, a Wall Street biotech analyst once married toGoogleco-founderSergey Brin.TheMountain View, California-based firm has more than 10 million customers and has collected 1 billion genetic data points, according to itswebsite. Brin and Google were early investors.

By contrast, 23Mofang is run out oftheChinese city of Chengdu, and Zhou, 36, is a computer science graduate who createdthecompany after becoming convinced Chinas next boom would be inthelife sciences sector. 23Mofang expects to have 700,000 customers bytheend of this year, a number he projects will at least double in 2020.

Thedivergence betweenthetwo countries andtheir regulation oftheindustry is just as palpable. Chinas race to dominate genetics has seen it push ethical envelopes, with scientistHe Jiankuisparking a global outcry last year by claiming to have editedthegenes of twin baby girls.Theexperiment, which He said madethem immune to HIV, put a spotlight on Chinas laissez-faire approach to regulating genetic science andthebusinesses that have sprung up around it.

When my reports came back, 23Mofangs analysis was much more ambitious than its American peer. Its results gauged how long I will live, diagnosed a high propensity for saggy skin (recommending I use products including Olay and Estee Lauder creams) and gave me an optimist not prone to mood swings a higher-than-average risk of developing bipolar disorder. 23andMe doesnt assess mental illness, which Gil McVean, a geneticist at Oxford University, says is highly influenced by both environmental and genetic factors.

Thefortune teller who pored over my palm told me I would live to be a very old woman. 23Mofang initially said I had a better-than-average chance of living to 95, before revisingtheresults to say 58% of clients hadthesame results as I did, making me not that special, and perhaps not that long-living.

When I ranthefinding pastEric Topol, a geneticist who foundedtheScripps Research Translational Institute in La Jolla, California, he laughed. Ninety-five years old?Theres no way to put a number on longevity, he said. Its a gimmick. Its so ridiculous.

Zhou saidtheaccuracy ofthelongevity analysis, based on a 2014 genetics paper, is not too bad, thoughthecompany plans to updatetheanalysis with research thats being undertaken on Chinese elderly.

But when it comes to disease,theresults of both companies showed howthescience of genetics, particularly attheconsumer level, is still a moving target.

Its All AbouttheData

After claiming I had a 48% greater risk thanthegeneral population of developing type 2 diabetes, both 23Mofang and 23andMethen revisedtheresults.

First, 23andMe cuttherisk figure from its analysis, posted in an online portal I accessed with a password.Theoverview analysis that I have an increased likelihood of developingthedisease never changed. But a few months later,thefigure was back, with a slightly different explanation: Based on data from 23andMe research participants, people of European descent with genetics like yourshave an estimated 48% chance of developing type 2 diabetes at some point between your current age and 80.

Shirley Wu, 23andMes director of health product, saidthecompany occasionally updates its analysis. My risk figure might have changed if I indicated my ethnicity and age, she said. I hadnt given any biographical details or filled out any surveys on 23andMes site.

Your risk estimates will likely change over time as science gets better and as we have more data, Wu said. We are layering in different non-genetic risk factors, and that potentially updates our estimates.

Algorithms and data underpintheanalysis of both companies, asthey do for other genetic testing firms, so it apparently isnt unusual forDNAanalysis to shift as more research and data into diseases becomeavailable. Still, I was confused.

I reached out to Topol, who said that 23andMes diabetes finding likely didnt apply to me sincethevast majority of people studied forthedisease are of European descent. Wu saidthe American company does have a predominantly European database but has increased efforts to gather data for other ethnicities as well.

23Mofang, meanwhile, also revised my diabetes risk to 26%. My genes hadnt changed, so why hadtheresults? CEO Zhou saidthecompany is constantly updating its research and datasets, and that may changetheanalysis. As time goes by,there will be fewer corrections and greater accuracy, he said.

For now, theres a possibility you can later get a result thats opposite oftheinitial analysis, said Zhou.

Additionally,theaccuracy of genetic analysis varies hugelydepending onthetraits and conditions tested because some are less genetically linkedthan others.

Zhou isnt deterred by criticism. He said 23Mofang employs big data and artificial intelligence to findthecorrelations to diseases without relying on scientists to figure it out.

While its impossible to get things 100% right,thecompanys accuracy will get better with more data, he said.

Ancestry Mystery

You might assume thatthetwo companies would offer similar analysis of my ancestry, which Ive long thought to be three-fourths Vietnamese and one-fourth Chinese (my paternal grandfather migrated from China as a young man). Born in Vietnam and raised intheUS, I now live in Hong Kong, a special administrative region of China.

23andMes analysis mirrored what I knew, but my ancestry according to 23Mofang? 63% Han Chinese, 22% Dai an ethnic group in southwestern China and 3% Uyghur. (It didnt pick up my Vietnam ancestry becausetheanalysis only compares my genetics to those of other Chinese, according tothecompany.)

That led me tothebig question in this grand experiment: How safe is my data afterthesetests?

Human Rights Watch said in 2017 that Chinese authorities collectedDNAsamples from millions of people in Xinjiang,thepredominately Muslim region thats home totheUyghur ethnic group. Chinas use of mass detention and surveillance intheregion has drawn international condemnation. What if Beijing compelled companies to relinquishdata on all clients with Uyghur ancestry? Couldthedetails of my Uyghur heritage fall into government hands and put me at risk of discrimination or extra scrutiny on visits to China?

23Mofangs response tothese questions didnt give me much solace. Regulations enacted in July gavethegovernment access to data held by genetics companies for national security, public health and social interest reasons.Thecompany respectsthelaw, said Zhou. Ifthelaw permitsthegovernments access tothedata, we will give it, he said.

Theauthorities havent made any requests for customer data yet, Zhou pointed out. Chinas State Council, which issuedtheregulations, andtheMinistry of Science & Technology didnt respond to requests for comment.

Over intheUS, 23andMe said it never shares customer data with law enforcement unlesstheres a legally valid requestsuch as a search warrant or written court order.Thecompany said its had seven government requests for data on 10 individual accounts since 2015 and has not turned over any individual customer data. It uses all legal measures to challenge such requests to protect customers privacy, said spokeswoman Christine Pai.

No Protection

New York Universitybioethics professorArt Caplansays privacy protections on genetic information are poor in most countries, including in the USand China.

I dont think anyone can say theyre going to protect you, he said. In China, its even easier for the government. The government retains the right to look.

23andMe appeals to potential customers with the lure of being able to make more informed decisions about your health, but after taking tests on both sides of the Pacific and realizing how malleable the data can be, as well as the myriad factors that determine diseases and conditions, I am left more skeptical than enlightened.

I gave away something more valuable than a vial of spit the keys to my identity. It could become a powerful tool in understanding disease and developing new medicines, but in the end its entrepreneurs like Zhou who will ultimately decide what to do with my genetic data. He plans to eventually look for commercial uses, like working with pharmaceutical companies to develop medicines for specific diseases.

We want to leverage the big database we are putting together on Chinese people, Zhou said. But first, we need to figure out how to do it ethically.

Read the original here:

How do consumer DNA tests from the US and China stack up? - Abacus

Scott LaFee: Don’t Think Too Hard About This – Noozhawk

By Scott LaFee | November 27, 2019 | 11:55 p.m.

Weve all heard the admonitions about how keeping mentally active boosts overall health and longevity. A new study suggests that busy brains might mean shorter lifespans, and excessive brain activity could be a risk factor for dementia.

Researchers documented the phenomenon across multiple species from humans to mice to roundworms (!) and said it appears people who live longer may have a regulatory gene that more effectively quiets unnecessary nerve activity.

They concede their findings appear counterintuitive and the full story in humans is likely to be much more complicated. So dont stop just yet taking those foreign language lessons, doing Sudoku and reading this column.

Adults have approximately 20,000 pores on their faces.

Of the 195 countries around the world, 119 were found to have an insufficient supply of blood units for health care and emergency use in 2017, according to a new study published in The Lancet Haematology.

Higher income countries were largely able to meet demand, but poor countries were not. South Sudan, for example, had a need 75 times greater than the countrys supply.

Its estimated that 10 to 20 donors can supply enough blood to help 1,000 people.

The 1992 book Sharks Dont Get Cancer spawned a huge increase in shark hunting as people sought shark parts as a treatment for various malignancies.

In fact, sharks do get cancer, and multiple studies have found no evidence that using shark cartilage or other tissues is an effective treatment for any type of cancer.

Cachexia: A complex syndrome associated with an underlying illness, such as cancer or AIDS, that results in ongoing muscle and weight loss that cannot be entirely reversed with dietary supplementation.

Nephophobia: Fear of clouds

The Major League Eating record for poutine is 28 pounds in 10 minutes, held by Joey Chestnut of San Jos.

Poutine is a Canadian dish consisting of French fries and cheese curds topped with brown gravy. In Quebec, where it is believed to originate, a plate of poutine is routine cuisine.

A mans health can be judged by which he takes two at a time pills or stairs. Joan Welsh

This week in 1974, Dr. Christiaan Barnard of Cape Town, South Africa, performed the worlds first twin heart operation, implanting a second human heart alongside the old one in a 58-year-old man.

In the procedure, Barnard removed only the diseased portion of the patients heart one-third of the left ventricle. He then joined the left atrium to the atrium of a second donor heart.

The operation was considered less radical than total heart replacement and was conducted without a heart-lung machine. With both hearts beating, the second acted as a booster for the first.

The patient died four months later, however, of unrelated causes.

Many, if not most, published research papers have titles that defy comprehension. They use specialized jargon, complex words and opaque phrases like nonlinear dynamics. Sometimes they dont, and yet theyre still hard to figure out.

Heres an actual title of actual published research study: Stimulae Eliciting Sexual Behavior.

In this case, the specific topic was the sexual behavior of turkeys, in which a pair of researchers at Pennsylvania State University in the early 1960s wanted to know just how minimal turkey stimulae might be to still do the job. So they created a mock female bird and progressively removed parts of the model, assessing when a male turkey lost interest.

Finally, they got to just a stick-mounted head and neck, which the male turkey found just as appealing a mate as a whole bird.

Q: What does your spleen do?

A: The spleen is an organ located between the stomach and diaphragm. It makes new white blood cells and cleans old ones out of the body. Its also a place where immune cells congregate. Though these cells are spread throughout the body, they sometimes need to talk with one another, which they do when meeting in the spleen or in lymph nodes.

A person can live without a spleen, but their immune system is substantially impaired. Some people have a second spleen, called an accessory spleen, that is very small but may grow and function when the main spleen is removed.

There are thousands of exercises, and youve only got one body but that doesnt mean you cant try them all:

Its called the Superman, an easy exercise to strengthen back, buttocks, hips and shoulders. Lie prone (face down) on a floor mat, legs extended, arms extended overhead with palms facing each other. Relax head to align with spine.

Exhale, contract abdominal and core muscles and slowly and simultaneously raise both legs and arms a few inches off the floor. Avoid any rotational movement. Maintain head and torso position. Dont arch back or raise head. Hold this position briefly.

Gently inhale, and lower legs and arms to starting positions without any movement in lower back or hips. Repeat.

Q: How many kinds of tonsils are there?

A: Four. The palatine tonsils are the ones seen at the back of the throat. But there are also lingual tonsils (base of the tongue), tubal tonsils (around the opening of the Eustachian tube in the nasopharynx, which is the upper part of the cavity behind nose and mouth) and adenoid tonsils (high up in the throat behind the nose).

All together, these tonsils form Waldeyers ring, which serves as a gatekeeper to all things entering the airways and digestive tract, grabbing pathogens and warding off diseases.

I will see you tomorrow, if God wills it. Pope John Paul I (1912-1978).

Apparently, God didnt. Pope John Paul I suffered a heart attack and was found dead in bed with reading material and his bedside lamp still lit. He had been pope for just 33 days.

Scott LaFee is a staff writer at UC San Diego Health and the former chief science writer at The San Diego Union-Tribune, where he covered science, medicine and technology. Click here to read previous columns. The opinions expressed are his own.

The rest is here:

Scott LaFee: Don't Think Too Hard About This - Noozhawk

Velocity launches and announces first close of pre-seed healthtech fund – BetaKit

Velocity has launched a new healthtech fund for early-stage startups. In its first close, the fund has reached 80 percent of its $1 million USD target.

Were on pace to create high impact global healthtech juggernauts for Canada based out of the Waterloo Region.

The Velocity Health Tech Fund represents the incubators second pre-seed fund and will make investments of $50,000 to support founders working in areas such as medical devices, therapeutics, diagnostics, digital health, and emerging health sector spaces. The fund, formed in partnership with Communitech, will also invest in the winners of the Velocity Fund Pitch Competition.

Velocity has not explicitly disclosed the funds LPs, but a press release named Dave Caputo, a past-chair of the board at Communitech and Richard Weinstein, an ophthalmologist based in Kitchener, as individual investors in the fund.

The rise in health technology companies incubating at Velocity reflects an increasing number of founders wanting to dedicate their energy and passion to simultaneously capture not only revenue from a multi-trillion dollar market, but also an opportunity to improve longevity and manage or cure disease, said Adrien Ct, Velocitys executive director.

RELATED: Outgoing director Jay Shah reflects on burnout as Velocity evolves leadership structure

The number of healthtech companies at Velocity has increased over the last six years, and over one-third of its incubated companies were in the healthtech sector in 2019. There are currently 27 healthtech startups being incubated at Velocity, and a third of those are in the process of, or have already completed, preclinical studies, while two are in human clinical trials.

Velocity stated that it has been reshaping its work to better meet the needs of healthtech companies. Last year, healthtech giant PerkinElmer moved its Canadian demonstration lab to Velocitys space. The incubator also said it has furthered its engagement with research labs likely to have healthtech spinouts, and has added business advisors with more healthtech experience.

In November, alumni and current companies of Velocity reached more than $1 billion CAD in venture capital since the incubator was launched 11 years ago. Velocity claims that since 2013, its incubated healthtech companies have gone on to raise over $50 million CAD in private investment.

More early-stage investment is required to fuel a thriving healthtech startups scene, said Caputo. Combined with the benefits of Velocitys highly differentiated startup resources and Communitechs scale-up programs, were on pace to create high impact global healthtech juggernauts for Canada based out of the Waterloo Region.

As our world faces growing (and already massive) challenges in human health, the commercialization of health technologies will be essential, Ct added. Simply put, its good business.

Image source Velocity

The rest is here:
Velocity launches and announces first close of pre-seed healthtech fund - BetaKit

Rich People Have Access to Better Microbes Than Poor People, Researchers Say – VICE UK

This article originally appeared on VICE US.

Our bodies are home to an abundance of tiny organisms, collectively called the microbiome, which are essential to human health and longevity. But not all microbiomes are equal, according to an essay published on Tuesday in PLOS Biology that spotlights how access to healthy microbes is profoundly interlinked with social and economic inequities.

A team led by Suzanne Ishaq, an assistant professor at the University of Maine and an expert in animal microbiomes, outlines examples of the human microbiomes sensitivity to discrepancies in healthcare, nutrition, and safe environmental standards. This microbial inequality, as the essay calls it, raises the question of whether a healthy microbiome should be a right or a legal obligation for governments to pursue on behalf of people.

The diet that you eat and your lifestyle can have dramatic impacts on the gut microbes that you recruit and the benefits or the negatives that you derive from them, said Ishaq in a call. If you dont even have access to a good quality diet, you might be suffering the effects of not having those beneficial microbes and products in ways you might not have imagined.

Gaps in microbial health can emerge before a person is even born, because some of the most important microbes are fostered in utero. The fetal microbiome is influenced by the mothers access to healthy foods as well as her stress levels, which can be amplified by economic inequities. The availability of maternity leave or social support also affects the amount of time that new mothers can devote to breastfeeding their babies, which is another critical factor in the establishment of a healthy microbiome.

These microbial patterns play out over our entire lifetimes. Populations with access to quality nutrition will have better physical and mental health outcomes than those that do not, and that is reflected on a gut microbial level. The environmental quality of the buildings where we live and work also influence what lifeforms are inside us, as does our general proximity to greenspace, on the positive side, or polluting industrial and agricultural facilities, on the negative end.

Ishaq had been ruminating about these connections in her research for years, and decided to teach a special course on the subject at the University of Oregon over the summer. Fifteen undergraduate students with a wide variety of majors participated in the class, and are now co-authors on the new paper. Because the majority of the class were not science majors, the essay has an interdisciplinary approach that concludes with legal and political implications of microbial inequality, in addition to the medical dimensions.

They were actually much more familiar with the social policies than I was, given their background, which was really cool, Ishaq said of her students.

One of the questions the team explored is whether a healthy microbiome can be considered a human right or a legal obligation. One 2011 paper touched on this issue through the lens of biobanking, or archiving of human tissue, but there has never been a major legal case that establishes who owns an individuals microbiome, or if people are legally entitled to a healthy microbiome.

From the perspective of Ishaq and her colleagues, the dynamic nature of the microbiome suggests that legal arguments should emphasize access to healthy microbes, rather than ownership over ones microbiome.

Youre picking up and putting off hundreds of thousands of microbial cells every day so to think that whats in your gut is completely yours is probably the wrong way to think about it, Ishaq explained. They are more like passengers than things that you own.

In other words, healthy microbes could potentially be categorized as an essential resource or common good, like clean water, safe environments, and quality public health. Ishaq hopes the essay will encourage researchers across disciplines to think about the human microbiome as both a metric of social inequities, and a roadmap to more effectively bridge those divides.

It tends to be people that werent even involved with polluting water or growing too much food or pouring chemicals everywhere that end up being the ones that have to deal with these microbial-related problems, she said.

Addressing this problem will require restructuring our societies on the largest scales, in order to ensure that the small-scale lifeforms inside us can thrive, so that we can too.

Read the rest here:

Rich People Have Access to Better Microbes Than Poor People, Researchers Say - VICE UK

Frankenstein vs. The Wolfman: Who Would Win (And Why) – Screen Rant

Frankenstein and The Wolf Man have met on the big screen once before inFrankenstein Meets The Wolf Man (1943), but the fight between the two of them, for the most part, didn't declare a clear winner.

Given the resurrection of Universal's "dark universe", modern audiences will soon see these beloved monsters on the big screen once more. Since they all exist in the same world, it would be very possible to, at some point, explore actual crossovers as has been done in the past with the franchise. With the popularity of crossover films likeFreddy vs. Jasonand ensemble films likeInfinity War, these crossovers could do really well and fans typically possess some sort of interest in exploring which of their favorite characters would best each other in a fight to the death.

Related: Penny Dreadful's John Clare Is The Most Underrated Frankenstein's Monster

Frankenstein vs The Wolf Man has been a popular idea before, most recently being used as a theme maze at the Hollywood Horror Nights and Halloween Horror Nights celebrations at Universal Studios in both Hollywood, California and Orlando, Florida. The concept was executed incredibly, but again, no clear victor was declared. So, in a grudge match between Frankenstein and The Wolf Man, who would win?

Frankenstein was originated in the novel of the same name in 1818 by Mary Shelley. His character was named after his creator, Dr. Victor Frankenstein and was given the title of "Frankenstein's monster". Dr. Frankenstein was an ambitious medical student who was trying to figure out how to reanimate the dead. The doctor's mysterious lab employed a dubious mix of chemistry and alchemy to perform his experiments, so the secret to Frankenstein's birth is unknown, leavinghis general powers and abilities slightly vague. The final ingredientthat brought him to life was when he was struck with lightning during a massive thunderstorm.

His reanimated status allows for him to be hardy and difficult to kill. Longevity wise, Frankenstein isimmortal. He is composed of different human body parts, and it could be argued that, based onhis composition, these parts would be susceptible to physical damage, though would still prove difficult due to his superhuman strength and durability. Frankenstein also possesses an incredible capacity for intelligence, which he demonstrated in the novel when he learned two languages fluently and could read and write at the age of six weeks. The novel also addresses that he's remarkably agile for his size and faster than a normal human, possessing the ability to swim the English Channel. His senses are keener than a human's. Also, while he does have some regenerative ability, it is slower. For example, if he was shot by a gun, he could heal on his own, but it would take weeks without medical attention.

The Wolf Man is based off werewolf tales of old, where a scratch or bite from a wolf can turn a man into a blend of human and wolf that is controlled by the full moon. The original film follows Larry Talbot, who gets bitten during an unexpected attack. Prior to this, Talbot obtained a walking stick with a decorative silver head from an antique shop, and learns about werewolves from his love interest, Gwen. After his attack, Talbot seeks out answers from a gypsy fortune teller when he suspects the folklore may be real, and learns that the wolf who attacked him was, in a fact, a werewolf and the gypsy woman's son.

Related: Silver Bullet Should Be The Next Stephen King Movie

Traditionally, werewolves have the obvious animal instincts associated with wolves: keen senses, speed, the ability to hunt and track, and sharp teeth and claws. Werewolves add to these abilities by bestowing the cursed with beyond average strength and speed, stronger than man and wolf. They are also more resilient than traditional wolves, being able to regenerate quickly from injury so long as they aren't done with silver, as this will injure them greatly and has the potential to kill when done so in a fatal blow. In the original film, he was killed with his walking stick. Since wolves are cursed by the full moon, once they've transformed, they lack the humanity they have the rest of the time, and the animal instincts take over. This is why, typically speaking, those afflicted hate being werewolves because they typically have no memory of what happened while they were a wolf.

The ending ofFrankenstein Meets The Wolf Manwas actually considered to be weak because it didn't declare a victor. A reviewer from The New York Times said that the film was "a great disappointment" since the fight was done sort of as an afterthought and had no conclusion. He also suggested that Universal should consider this mash-up again in the future. Given the statistics on both monsters, The Wolf Man is the winner, but situationally, this fight could go either way. Overall, the werewolf's primary advantage over Frankenstein's monster is that he possesses animal instincts that would aid him and allow him to attack with abandon, where Frankenstein has humanity, reason, and would certainly defend himself against a creature, but might not be as aggressive in the fight.

Also, Frankenstein is composed of human parts, and since he was stitched together, the Wolf Man's teeth and claws could likely shred him with relative ease. Frankenstein could kill the Wolf Man if he had the proper tools for the job, which, given his intelligence, he could obtain and use, but if he was unprepared for the fight, it wouldn't go in his favor.

Next: Who Is The Invisible Man: Origin & Powers Explained

Xavier's Daughter Is Taking Over An Entire Marvel Empire

Tags:the wolfman,frankenstein

See original here:

Frankenstein vs. The Wolfman: Who Would Win (And Why) - Screen Rant

Liberty Science Center’s Inaugural Genius of New Jersey to Honor Innovators Who Make the State a World Leader in Cutting-Edge Applied Science -…

JERSEY CITY, N.J.--(BUSINESS WIRE)--New Jersey is home to some of the worlds most accomplished innovators in applied science. Three of them who are pioneering research and solutions in antibacterial therapies, genetics, human life extension, and food production are being honored by Liberty Science Center at its inaugural The Genius of NJ celebration on Monday, December 2.

The celebration starts at 5:30 pm with cocktails and unique technology demonstrations: a full-body 3D scanner from Lenscloud that can scan a person in half a second with 120 cameras and create a realistic 3D avatar; bomb-disposing robots and an autonomous fighting robot from Picatinny Arsenal; and Flyer, a personal aerial vehicle from Kitty Hawk, headquartered in Mountain View, CA.

The New Jersey honorees are Bonnie Bassler, Chair of Molecular Biology at Princeton University, who is developing novel antimicrobial therapies to render pathogenic bacteria harmless; Dr. Robert J. Hariri, Chairman, Founder & CEO of Celularity, Inc. who is pioneering the use of stem cells to cure disease and slow aging; and David Rosenberg, CEO and Co-Founder of AeroFarms, the worlds leader in mass-scale vertical indoor farming.

Our inaugural Genius of NJ Award Winners represent the best this state and the world have to offer in harnessing science for the betterment of humanity, said Liberty Science Center President and CEO Paul Hoffman. Each is using his or her exceptional intellect and creative abilities to disrupt and innovate both in their respective fields and in their commitment to making the world healthier and safer.

Bonnie Bassler is the Squibb Professor of Molecular Biology and Chair of the Department of Molecular Biology at Princeton University, as well as a Howard Hughes Medical Institute Investigator. Professor Bassler deciphered the chemical language bacteria cells use to communicate by studying a harmless marine bacterium called Vibrio fischeri, known to bioluminesce, or make light, like fireflies do. She is a winner of the MacArthur Genius Grant and is now developing therapies that disrupt communication among harmful bacteria and strengthen communication among helpful bacteria. At a time when an increasing number of bacteria are resistant to traditional kinds of antibiotics, Dr. Bassler offers a promising new approach to antimicrobial therapy.

The Chairman, Founder and CEO of Celularity, Inc., in Warren, NJ, and Co-Founder and Vice Chairman of Human Longevity, Inc., Dr. Robert Hariri is the quintessential renaissance man. Hes a neurosurgeon, a medical researcher, and a serial entrepreneur in two technology sectors: aerospace and biomedicine. Dr. Hariri has advised the Vatican on genetics, and in 2018, Pope Francis bestowed on him the Pontifical Key Award for Innovation. Dr. Hariris path to discovering that the placenta, a temporary organ discarded after birth, was a potent source of stem cells began in the 80s when he viewed a first trimester ultrasound of his oldest daughter and wondered why the placenta was so large. Today Dr. Hariri is working to use placental stem cells to cure disease, slow aging, and augment healthy human lifespan.

Prominent entrepreneur David Rosenberg, CEO and Co-Founder of AeroFarms, set out to reinvent one of the most basic aspects of food production, farming. AeroFarms has grown 800 species of plants indoors and can grow them 365 days a year without sun or soil, achieving yields 130 times greater than conventional farming. His system uses 95 percent less water than field farming and no pesticides, herbicides, or fungicides. Rosenbergs adoption of cutting-edge technology has been a cornerstone of AeroFarms, which set up its first indoor vertical farms in abandoned warehouses in Newark. He employs plant biologists, microbiologists, geneticists, systems engineers, and data scientists. AeroFarms innovations in indoor vertical farming have improved not just plant yields but also taste, texture, nutritional density, and shelf life.

Additionally, LSC will honor non-New Jersian Sebastian Thrun, CEO of Kitty Hawk, a company spun off from a Google moonshot effort to free the world from traffic. Kitty Hawk is developing all-electric, vertical take-off flying machines for everyday use. Known as the godfather of self-driving cars, as a Stanford professor in 2005, Thrun led a team that won the $2-million Defense Department Grand Challenge to build an autonomous vehicle which drove itself unassisted on a 132-mile course across the Mojave Desert. His winning entry, Stanley, is now on display at the Smithsonian in Washington, DC. While at Stanford, in 2011 he and colleague Peter Norvig offered their Introduction to Artificial Intelligence course online to anyone, for free. Over 160,000 students in more than 190 countries enrolled! The MOOC (which stands for Massive Open Online Course) was born, and Thrun founded the online education company Udacity, with the goal of democratizing education. Thrun relinquished his tenured Stanford professorship to join Google and founded the companys semi-secret R&D division called Google X (now called simply X) to develop breakthrough technologies, such as self-driving cars, that make the world a radically better place.

Ticket prices for The Genius of NJ start at $750 per guest with options for table sponsorship from $12,500 to $50,000. For more details, please visit The Genius of NJ online. All proceeds from this event will support LSCs mission to inspire the next generation of scientists and engineers.

About Liberty Science Center

Liberty Science Center (LSC.org) is a 300,000-square-foot nonprofit learning center located in Liberty State Park on the Jersey City bank of the Hudson near the Statue of Liberty. Dedicated to inspiring the next generation of scientists and engineers and bringing the power, promise, and pure fun of science and technology to learners of all ages, Liberty Science Center houses the largest planetarium in the Western Hemisphere, 12 museum exhibition halls, a live animal collection with 110 species, giant aquariums, a 3D theater, live simulcast surgeries, a tornado-force wind simulator, K-12 classrooms and labs, and teacher-development programs. More than 250,000 students visit the Science Center each year, and tens of thousands more participate in the Centers off-site and online programs. Welcoming more than 750,000 visitors annually, LSC is the largest interactive science center in the NYC-NJ metropolitan area.

See the original post:

Liberty Science Center's Inaugural Genius of New Jersey to Honor Innovators Who Make the State a World Leader in Cutting-Edge Applied Science -...

Dr. Ronnie S. Stangler: What Does Madonna Know About Her Genes That You Don’t? Genomics and Its Impact on Families of Wealth | Horizons: Family Office…

Ronnie S. Stangler, M.D., physician and psychiatrist, is Founder of Genome Advisory, based in New York City. Uniquely positioned at the intersection of health, wealth and science, Genome Advisory consults with individuals, global families and their advisors, using the DNA science of genomics to enhance strategic plans regarding health, risk and legacy.

Dr. Stangler served for over a decade as Chief Medical Officer to an international family office in London, Liechtenstein and Switzerland.

She is Clinical Professor of the Department of Psychiatry and Behavioral Sciences at the University of Washington, and contributed as Advisor to the Department of Genetics, Personal Genetics Education Project, Harvard Medical School.

When Madonna performs, she reportedly engages a sterilization team to sweep, mop and wipe every surface of her dressing room, so that no trace of her DNA is left for surreptitious analysis, cloning or experimentation. Hacking portends the specter of a black market which will trade in valuable genetic information about prominent individuals and families. Is Madonna paranoid? Or smart? You decide...

2020: THE AGE OF THE GENOME

The DNA science of genomics is now a critical part of strategic planning regarding health, risk and legacy for wealthy individuals, global families and their advisors.

Every living organism is made up of cells. Each cell contains a set of genes encoded with DNA which provides comprehensive instructions that constitute the master blueprint for our lives. In conjunction with environment and lifestyle, our genes are responsible for determining fundamentals of who we are: our appearance; traits; how we survive and prosper; how we age; how we decline.

Genes are our universal inheritance and legacy. They have been so since the onset of humankind. Historically they have been an invisible presence. Until now.

We have entered the Age of the Genome, an extraordinary era of transformative biotechnology. Today, we can not only fully see our genes - an essential building block of our humanity - but we can read them like the words of a book. And now we can edit, enhance and create genes, as well.

GENETICS vs GENOMICS

Genetics is the study of heredity and individual genes. Many of us first learned about genetics in high-school biology as we contemplated Mendels pea plant experiments of the 1860s.

Genomics is the study of an organisms complete set of genes, called the genome, the entirety of its DNA. The genome can be analyzed through a process called whole genome sequencing (WGS).

The first human genome was sequenced in 2003. This fifteen year project cost over $3B. Today, we can analyze the human genome for less than $1,000 within weeks. Personal motivations for WGS currently include: accessing health information, often providing actionable insights; understanding disease risk; knowing what one will pass on to ones children; and receiving information about response to particular medications (pharmacogenomics).

GENOTYPING vs WHOLE GENOME SEQUENCING

While DNA and genes are now very much a part of public consciousness, propelled mostly by widespread adoption of direct-to-consumer (DTC) genotyping products (e.g. 23andMe, Ancestry.com, etc.), few understand the specifics of what these products offer.

The technology underlying direct-to-consumer genetic analyses is genotyping, which provides a limited picture of less than one percent of ones genes, preselected by individual companies on the basis of known associations with specific traits and diseases.

Alternatively, whole genome sequencing provides a literal snapshot of the entirety of ones genes. Some have compared the difference between genotyping and WGS to the difference between a tricycle and a race car.

GENOMICS AND WEALTH

The wealthy represent a population with the same concerns about health and genes as all others. However, factors in their environment generate unique concerns. The very terms family enterprise, family office and family legacy convey their requisite focus on all that is family. And genes permeate all aspects of family.

Traditionally the wealthy have focused on financial well-being, preservation and growth of capital. New knowledge of family genes will progressively influence all aspects of health, physical and emotional well-being; reproduction and family relationships; as well as the most traditional domains of family advising and operation of family enterprise. And the wealthy are already amongst the earliest adopters of cutting-edge DNA science.

Genomic information is already being used to inform best decisions around health, risk and legacy. Thus, knowledge of genomics and its impact on wealthy families is now part of an essential toolkit for the family advisory. Preeminent families have already embraced planning of genomics strategy.

VIEWING THE FAMILY OFFICE THROUGH THE LENS OF GENOMICS

Genomics has moved from an abstract quantitative entry in investment portfolios to a vital living tool for creating healthier, longer, disease-free lives.

How can we consider succession without considering genes??Heredity is succession. It is the succession of genes. How will succession planning be affected by knowledge of health futures of family members?

How can we consider trusts without considering genes??As we learn more about health risks, there are profound financial and social implications. If a family member has significant likelihood of imminent disease, appropriate planning is critical. What family resources should be allocated to access new mitigating interventions? Early gene- editing therapies are extremely costly, and no matter how wealthy a family, resources are finite.

How can we consider estate planning without considering genes??Radical longevity and the genetic means to achieve it will alter financial requirements. New financial instruments must be developed to accommodate increased lifespan.

How can we consider fiduciary responsibility without considering genes??Trustees and advisors will be challenged by new medical information that is difficult to interpret. Deciding how to utilize this information creates unprecedented ethical dilemmas. Families must align on an ethical framework to guide such decisions.

How can we consider governance without considering genes??Governance must reflect a common family vision with the understanding that genetics is not a solo sport. Every biologically related family member is literally tied to every other by the life thread of shared DNA.

How can we consider next-gen without considering genes??Next-gen have access to rapidly evolving radical reproductive technologies. They must also navigate new relationships with parents who may be physically and mentally vital well into their nineties and beyond. Parents may wish to continue their tenure within the family enterprise. This will create new frictions. Parents may also choose to create genetically enhanced new children, perhaps younger by an entire generation than their older siblings.

DEVELOPING A GENOMICS STRATEGY FOR YOUR FAMILY AND FAMILY OFFICE

Family offices are as unique as the families they serve. Genomics strategy must be developed to support families as they navigate the complex field of genomics and engage with the science directly.

Human and behavioral perspectives cannot be ignored. Genomic information will have an impact on family dynamics; family identity; and the psyches of individuals who learn about new health risks, vulnerabilities and opportunities for enhancement.

Wealthy families are already formalizing family genomics chartersto guide ethical decision making, now and through the future.

Genes are rarely absolute destiny. Our environment and life experiences profoundly alter the expression of genes. Will knowledge of genes spur us to better life choices? Change is challenging. Family members require high-touch support to alter behavior in positive ways.

There is dire need, as well, for trustees and advisors to understand the complex nature of systems of wealth and to integrate rapidly evolving biological considerations through processes when appropriate and beneficial to do so. Trustees and advisors will help determine how decisions are made; where sensitive data is saved; who has the right to access such data and when; and how resources will be allocated.

Families of wealth have the financial means to direct education and funding of medical initiatives of unique concern, as well as the potential to fund more generative, legacy and aspirational projects.

For example, when Sergei Brin, Co-Founder of Google, learned about his genetic vulnerability to Parkinsons Disease, he radically altered his philanthropic strategy to support basic science research in the field. After changing the way the world searches for information on the web, he has now revolutionized how scientists approach Parkinsons Disease.

Genomics will inevitably become an essential component of the family philanthropy portfolio in highly personal ways.

RISK MITIGATION FOR UHNW FAMILIES

Risk mitigation is a core responsibility in management of UHNW families and wealth. Direct- to-consumer genetic testing products present risks that must be contained immediately.

In December 2019, the United States Pentagon provided strong caution about the use of consumer genetic products by the military (Pentagon Warns Military Personnel Against At-Home DNA Tests, The New York Times, 24 December 2019).

Legal professionals have spoken out as well: Collecting [genetic] data could have unintended consequences. It can be lost to hackers, spies, others who might steal it... or exposed in government investigations through subpoenas... So people planning to plaster their deepest internal and family secrets into private company databases should consider the risks that the private DNA mills dont want you to think about. (The Shell Game Played with Your DNA, or 23 and Screwing Me, The National Law Review, 23 January 2020).

These groups represent a mere handful of increasingly concerned entities who detail gross compromise of privacy, security and accuracy. And Madonna saw it coming!

As a predominantly unregulated industry, DTC genetic testing entities often provide misleading information based on pseudoscience, making undeliverable promises. At times they offer false and dangerous reassurance about lack of medical vulnerability. For example, 23andMe only tests for three variants of BRCA genes responsible for breast and ovarian cancer, although more than 1,000 BRCA variants are known to increase cancer risk. 90% of participants who carry a BRCA mutation would be missed by todays 23andMe test.

Families of wealth, who require safety, security and privacy at all costs, must reject these at-home testing products entirely. The infotainment they provide is not an acceptable trade-off for the risks they impose, especially compromised safety.

By contrast, the whole genome sequencing industry is strictly regulated, governed by law and operates with the highest evidence-based technical medical standards and protection requirements for those whom they serve. Whole genome sequencing presents a far superior alternative for families of wealth.

Sequencing itself is but the first step of a life-long genomics journey. Once you have been sequenced, interpretation of your raw genomic data is a dynamic process, constantly evolving. New and increasingly complex insights will become available at exponential speed. Professional guidance is an absolute requirement to optimize translation and enhance health.

Imagine the following scenario:

A highly educated, vital, healthy 35 year-old family member is appointed CEO of the core global family enterprise. He dies at his desk from an unanticipated cardiac event on the second day of his tenure.

Consider the profound emotional and social impact of such an event on his family, the family office and the larger family organization. And consider the economic risk of not anticipating such an event, especially as this silent medical condition might have been understood using currently available DNA medical science through whole genome sequencing (Predicting Sudden Cardiac Death, The Harvard Gazette, 16 November 2019).

THE FUTURE

Families of wealth, family offices and family enterprise will ultimately be enriched by the gifts of genomics. This disruptive, deeply intimate human science bodes an extraordinary future with elimination of malignant disease, enhanced well- being and healthy longevity.

With new knowledge and agency comes new fiduciary responsibility to protect the lives of those we serve. We must all wrestle with its challenges, especially its ethics. Arming families with a working knowledge of genomics and a formal blueprint for its ethical application allows them to shape their most powerful legacy and future.

See the original post:
Dr. Ronnie S. Stangler: What Does Madonna Know About Her Genes That You Don't? Genomics and Its Impact on Families of Wealth | Horizons: Family Office...

(2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,…

Precision Medicine SoftwareMarket 2020: Inclusive Insight

Los Angeles, United States,June 2020:The report titled Global Precision Medicine Software Market is one of the most comprehensive and important additions to Alexareports archive of market research studies. It offers detailed research and analysis of key aspects of the global Precision Medicine Software market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Precision Medicine Software market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Precision Medicine Software market is carefully analyzed and researched about by the market analysts.

Precision Medicine Software Market competition by top manufacturers/ Key player Profiled: Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Inc, Lifeomic Health

Get PDF Sample Copy of the Report to understand the structure of the complete report:(Including Full TOC, List of Tables & Figures, Chart) : https://www.alexareports.com/report-sample/867663

Global Precision Medicine Software Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020- 2025. According to the latest report added to the online repository of Alexareports the Precision Medicine Software market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.

Based on region, the globalPrecision Medicine Software market has been segmented into Americas (North America ((the U.S. and Canada),) and Latin Americas), Europe (Western Europe (Germany, France, Italy, Spain, UK and Rest of Europe) and Eastern Europe), Asia Pacific (Japan, India, China, Australia & South Korea, and Rest of Asia Pacific), and Middle East & Africa (Saudi Arabia, UAE, Kuwait, Qatar, South Africa, and Rest of Middle East & Africa).

Precision Medicine Software Market Segment by Type covers: Cloud-based, On-premise

Precision Medicine Software Market Segment by Industry: Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Others

After reading the Precision Medicine Software market report, readers get insight into:

*Major drivers and restraining factors, opportunities and challenges, and the competitive landscape*New, promising avenues in key regions*New revenue streams for all players in emerging markets*Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions*Demand and uptake patterns in key industries of the Precision Medicine Software market*New research and development projects in new technologies in key regional markets*Changing revenue share and size of key product segments during the forecast period*Technologies and business models with disruptive potential

Key questions answered in the report:

What will the market growth rate of Precision Medicine Software market?What are the key factors driving the global Precision Medicine Software market size?Who are the key manufacturers in Precision Medicine Software market space?What are the market opportunities, market risk and market overview of the Precision Medicine Softwaremarket?What are sales, revenue, and price analysis of top manufacturers of Precision Medicine Software market?Who are the distributors, traders, and dealers of Precision Medicine Software market?What are the Precision Medicine Software market opportunities and threats faced by the vendors in the global Precision Medicine Softwareindustries?What are sales, revenue, and price analysis by types and applications of Precision Medicine Softwaremarket?What are sales, revenue, and price analysis by regions of Precision Medicine Software industries?

Get a discount on this report now at https://www.alexareports.com/check-discount/867663

Table of ContentsSection 1 Precision Medicine Software Product DefinitionSection 2 Global Precision Medicine Software Market Manufacturer Share and Market Overview2.1 Global Manufacturer Precision Medicine Software Shipments2.2 Global Manufacturer Precision Medicine Software Business Revenue2.3 Global Precision Medicine Software Market Overview2.4 COVID-19 Impact on Precision Medicine Software IndustrySection 3 Manufacturer Precision Medicine Software Business Introduction3.1 Syapse Precision Medicine Software Business Introduction3.1.1 Syapse Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.1.2 Syapse Precision Medicine Software Business Distribution by Region3.1.3 Syapse Interview Record3.1.4 Syapse Precision Medicine Software Business Profile3.1.5 Syapse Precision Medicine Software Product Specification3.2 Allscripts Precision Medicine Software Business Introduction3.2.1 Allscripts Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.2.2 Allscripts Precision Medicine Software Business Distribution by Region3.2.3 Interview Record3.2.4 Allscripts Precision Medicine Software Business Overview3.2.5 Allscripts Precision Medicine Software Product Specification3.3 Qiagen Precision Medicine Software Business Introduction3.3.1 Qiagen Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.3.2 Qiagen Precision Medicine Software Business Distribution by Region3.3.3 Interview Record3.3.4 Qiagen Precision Medicine Software Business Overview3.3.5 Qiagen Precision Medicine Software Product Specification3.4 Roper Technologies Precision Medicine Software Business Introduction3.5 Fabric Genomics Precision Medicine Software Business Introduction3.6 Foundation Medicine Precision Medicine Software Business IntroductionSection 4 Global Precision Medicine Software Market Segmentation (Region Level)4.1 North America Country4.1.1 United States Precision Medicine Software Market Size and Price Analysis 2014-20194.1.2 Canada Precision Medicine Software Market Size and Price Analysis 2014-20194.2 South America Country4.2.1 South America Precision Medicine Software Market Size and Price Analysis 2014-20194.3 Asia Country4.3.1 China Precision Medicine Software Market Size and Price Analysis 2014-20194.3.2 Japan Precision Medicine Software Market Size and Price Analysis 2014-20194.3.3 India Precision Medicine Software Market Size and Price Analysis 2014-20194.3.4 Korea Precision Medicine Software Market Size and Price Analysis 2014-20194.4 Europe Country4.4.1 Germany Precision Medicine Software Market Size and Price Analysis 2014-20194.4.2 UK Precision Medicine Software Market Size and Price Analysis 2014-20194.4.3 France Precision Medicine Software Market Size and Price Analysis 2014-20194.4.4 Italy Precision Medicine Software Market Size and Price Analysis 2014-20194.4.5 Europe Precision Medicine Software Market Size and Price Analysis 2014-20194.5 Other Country and Region4.5.1 Middle East Precision Medicine Software Market Size and Price Analysis 2014-20194.5.2 Africa Precision Medicine Software Market Size and Price Analysis 2014-20194.5.3 GCC Precision Medicine Software Market Size and Price Analysis 2014-20194.6 Global Precision Medicine Software Market Segmentation (Region Level) Analysis 2014-20194.7 Global Precision Medicine Software Market Segmentation (Region Level) AnalysisSection 5 Global Precision Medicine Software Market Segmentation (Product Type Level)5.1 Global Precision Medicine Software Market Segmentation (Product Type Level) Market Size 2014-20195.2 Different Precision Medicine Software Product Type Price 2014-20195.3 Global Precision Medicine Software Market Segmentation (Product Type Level) AnalysisSection 6 Global Precision Medicine Software Market Segmentation (Industry Level)6.1 Global Precision Medicine Software Market Segmentation (Industry Level) Market Size 2014-20196.2 Different Industry Price 2014-20196.3 Global Precision Medicine Software Market Segmentation (Industry Level) AnalysisSection 7 Global Precision Medicine Software Market Segmentation (Channel Level)7.1 Global Precision Medicine Software Market Segmentation (Channel Level) Sales Volume and Share 2014-20197.2 Global Precision Medicine Software Market Segmentation (Channel Level) AnalysisSection 8 Precision Medicine Software Market Forecast 2019-20248.1 Precision Medicine Software Segmentation Market Forecast (Region Level)8.2 Precision Medicine Software Segmentation Market Forecast (Product Type Level)8.3 Precision Medicine Software Segmentation Market Forecast (Industry Level)8.4 Precision Medicine Software Segmentation Market Forecast (Channel Level)Section 9 Precision Medicine Software Segmentation Product Type9.1 Cloud-based Product Introduction9.2 On-premise Product IntroductionSection 10 Precision Medicine Software Segmentation Industry10.1 Healthcare Providers Clients10.2 Pharmaceutical and Biotechnology Companies Clients10.3 Research Centers and Government Institutes Clients10.4 Others ClientsSection 11 Precision Medicine Software Cost of Production Analysis11.1 Raw Material Cost Analysis11.2 Technology Cost Analysis11.3 Labor Cost Analysis11.4 Cost OverviewSection 12 Conclusion

Do Inquiry About The Report Here: https://www.alexareports.com/send-an-enquiry/867663

About Us:Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data.

Contact Us:Alexa ReportsPh no: +1-408-844-4624Email: [emailprotected]Site: https://www.alexareports.com

Originally posted here:
(2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,...

Audit: NCDOT overspent on raises by nearly $40M – South Charlotte Weekly

By Nyamekye Daniel

(The Center Square) The N.C. Department of Transportation spent $39 million more than it should have on pay raises in 2018, a newly released state audit found.

State Auditor Beth Wood said NCDOT did not follow state law that directs the agency to issue certain salary adjustments to employees as long as they forfeited lump sum payments based on seniority and do not exceed payroll expenses by 2%, or $11.7 million.

Wood said NCDOT issued $58.5 million in salary adjustments to more than 7,000 employees for the fiscal year that started July 1, 2018. As a result, Wood said NCDOT gave its employees an unfair advantage.

NCDOT Secretary Eric Boyette said the auditor misinterpreted the law, which launched a pilot program that helps retain state employees.

Boyette said employees were not required to relinquish their career status or longevity pay to get the pay raises. Longevity pay is annual 1.5% to 4.5% bonuses given to employers with at least 10 years of service.

Boyette said the law allowed employees to be exempt from State Human Resources Commission rules that dictate compensation for hours worked, paid time off, sick leave, promotions, transfers and incentive pay.

The pay increases that are meant to make the salaries competitive with the private sector would be superfluous if they were contingent on employees giving up the longevity pay or their status as a permanent employee, Boyette said.

Boyette contends the pilot program, which ended June 30, allowed NCDOT to use 2% of its funding and reserves to issue the pay raises, according to the agencys interpretation of the law. He said NCDOT confirmed with lawmakers before and after the legislation was approved. Raises that consist of 2% of the agencys payroll would not have allowed the salaries to be competitive with the private sector, Boyette said.

The law states: For the 2018 2019 fiscal year and the 2019 2020 fiscal year, the sum equal to 2 percent of the total Highway Fund and Highway Trust Fund appropriation for the applicable fiscal year for the payroll expenses of the Department may be used.

The state auditors office confirmed the intent of law with the Joint Legislative Transportation Oversight Committee and the General Assemblys Fiscal Research Division. It also was published in the Joint House and Senate Committee on Appropriations Conference Report in 2018.

It states NCDOT has the flexibility for a period of two years in setting salaries for DOT employees who voluntarily relinquish longevity and career status. It also enables DOT to use up to 2% or $11.7 million per payroll for the purpose of salary adjustments, reallocation of positions, retention and recruitment programs.

Wood said the legislative oversight committee should review the process and the agency needs to correct the mistake.

The audit, which was released July 8, is the second critical state audit of NCDOT this year.

Wood reported in May the agency spent $742 million over its $5.9 billion spending limit for fiscal year 2019 and maxed out its cash balances. The General Assembly passed a bill last month that increases financial oversight of NCDOT.

Did you like this? Share it:

Visit link:
Audit: NCDOT overspent on raises by nearly $40M - South Charlotte Weekly

Consequences to Indian Economy Set to Exceed Loss of Lives by Coronavirus – The Citizen

Its been three weeks since the WHO declared a Covid2019 pandemic. It is not the worlds first coronavirus. We have had SARS, MERS, H1N1, swine flu and the like, some with much higher case fatality.

But this is unique in its sweeping virulence. The Centers for Disease Control (CDC) says the annual percentage of the U.S. population infected with the flu is about 8%, which translates to 26 million people a year. Of these, the CDC estimates that up to 60,000 persons die. It stands to reason that many more in India get afflicted by flus and influenzas each year, possibly with larger fatalities.

Given this knowledge and some very recent hindsight, it is time to sit back and objectively reconsider the draconian policy measures unleashed in India. The four hours to midnight order for a nationwide curfew to enforce social distancing has caught our public and public administration woefully unprepared.

The consequences of Covid2019 to the Indian economy and consequent loss of lives and longevity, seems very likely to exceed the loss due to any mass spread of the virus.

Epidemiological studies put out at several well regarded institutions such as MIT and the Global Virus Network (GVN) seem to suggest that this particular coronavirus is endemic in populated areas falling in temperature band of 3-17C with a humidity between 51 -79%. These initial findings suggesting a correlation between latitude and incidence have the powerful endorsement of Dr. Robert Gallo, the famed virologist and GVN head.

Mind you it has been just a few months Covid2019 jumped species by finding home in human beings. Covid2019s natural reservoir, seems to be bats, like the earlier coronaviruses SARS and MERS. But the fact remains the spread of Covid2019 has been faster in areas with colder climes.

The essential facts about Covid2019 is that while it is virulent, its fatality is around 1% and this is principally concentrated among the elderly and already ailing. Its symptoms are mostly akin to common seasonal flus often attributed to change of season etc.

Covid2019 can only be confirmed by testing and the cheapest test costs about Rs.5000 each. Clearly we cannot afford to test enough which simply means we wont ever know how many are truly afflicted by Covid2019.

The average life expectancy of Indians is 68.7 years. The above 65 years cohort accounts for only about 6% of India, which suggests that the incidence of fatality here will be lower.

Bubonic plague has a mortality of over 80%, while even diphtheria has a mortality rate of 32%. Covid2019 is not a killer virus.

In the developed countries like USA, Italy and elsewhere with substantially higher life expectancy, the 70+ years cohorts are much bigger. The mortality rate due has been the highest in Italy with about 9%. Almost 86% of the Italians who died were over 70 years. Italy has the second oldest population in the world after Japan, with over 23% over 65 years. Experts believe this was the determining factor in its high fatality rate.

The goal of social distancing is a hugely unfulfilled aspiration. The poor in India live cheek by jowl, with densities often exceeding 60000 per sq.miles. India has over 410 million workers in the unorganized sector, the vast majority of whom are daily wagers making a little more than the prescribed official wages and often much below that.

This working age cohort is mostly made up of younger Indians. The youthful age group (14-35 years) accounts for about 34% of Indias population. This cohort is about as much as the 35-65 years cohorts. Thus, even if the pandemic is real for India, the fatality due to it will be very low. The vast majority of Indians who might get infected by Covid2019 virus wont even know it.

Now assume that the Covid2019 pandemic will overwhelm India, and consider Indias abysmal health care scene. We have 6 physicians; 9 hospital beds and 13 nurses per 10,000 people. Nationwide we have less than 40000 ventilators and only 70000 intensive care beds (ICU). This calls for a policy that will help stagger the load and allow immunity to build up without overwhelming the critical care system.

Harvards Yonatan Grad, Professor of Immunology and Infectious Diseases, and colleagues conducted research on how to prevent overwhelming the U.S. health care system during the pandemic. This indicates the only possible method for dealing with the epidemic may be multiple intermittent social-distancing periods that ease up when cases fall to a certain level and then are reimposed when they rise past a key threshold.

As time passes and more of the population gains immunity, they said, the restrictive episodes could be shorter, with longer intervals between them. Clearly the nationwide simultaneous social distancing imposition was not only but also ill conceived.

The IMF has now announced a global recession due to disrupted supply chains and contraction of consumption. In India, consumption (C) accounts for 63% of GDP. Given GDP is = C + I + G + (X M) or GDP = private consumption (C) + gross investment (I)+ government investment + government spending (G) + (exports imports), the impact of the collapse of private consumption of the economy can be easily understood.

Many respected analysts are agreed that it will be no less than 20-30% in Q1. The government pledged to step up its spending by Rs.1.7 lakh crores. We wont go into how this was arrived at now, but just consider how inadequate it is compared to the hit taken by consumption? The government clearly needs to do more. It needs to pull out all stops to do this.

Where is the money is the question? Even if it sequestered 20% of the cash reserves with our to 100 corporations, it will be substantial.

The top 10 corporations alone have a hoard of over Rs.10 lakh crores. (Reliance has cash reserves of Rs.398,000 crs. TCS has almost Rs.100,000 crs, ITC has Rs.60,000 crs.) Our government wage and pensions bill accounts for 11.4% of GDP. Holding back only 10% of this or just the annual LTC will fetch the state and central governments over Rs.2 lakh crores.

It only calls for will and vision to accumulate the cash to begin reconstruction of a devastated economy. The pain cannot and must not be borne by the poorest alone. Modi has formidable communication skills and he must use it now.

Read the original:
Consequences to Indian Economy Set to Exceed Loss of Lives by Coronavirus - The Citizen

Forget CBD. Mushrooms Are the Beauty and Wellness Superfood You Need Right Now – Robb Report

The humble mushroom is the new superfood (or super fungus), and its taking center stage in a number of new topical and ingestible products touted for boosting the immune system, increasing skins moisture and even fighting inflammation. But can the simple mushroom live up to all this hype?

The experts we spoke with say mushrooms health and beauty powers are legitimate but dont pertain to the grocery store variety or the psychedelic drug. Instead, the in-demand fungi are a new class of supercharged mushrooms. Theyre actually superfoods on steroids because theyre adaptogens, says dermatologist Dennis Gross, founder of the Dr. Dennis Gross skin-care line. Adaptogens are herbal pharmaceuticals that do exactly as their name suggests: calibrate their powers to their environment or, if used in potent-enough doses, our beauty and health needs, and help combat the physiological effects of stress.

Fungi are the ultimate longevity experts, managing to pave their way through a billion years of life, says Tonya Papanikolov, a holistic nutritionist and founder and CEO of Rainbo, a line of ingestible mushroom supplements. From a wellness perspective, they increase the bodys immunity and resilience to stress and have the ability to enhance brain functions, too.

Skin-care brands are using mushrooms to counteract the effects of stress on the skin, increase moisture and improve circulation. Gross is using encapsulated Chaga, Cordyceps, Trametes versicolor and maitake mushrooms in his B3Adaptive SuperFoods serum, eye cream and moisturizer. Mushrooms have also popped up in products from Moon Juice, Dr. Andrew Weil for Origins, Natura Bisse, Blithe, BeautyStat and Macrene Actives. As the cosmetic chemist and BeautyStat founder Ron Robinson points out, there are thousands of mushroom varieties and little data on what each one does for the skin. Still, he says, the ones he has tried do meet expectations. When Im formulating, Im looking for compounds that are anti-inflammatory, that hydrate, that exfoliate; and is it going to provide antioxidant protection and damage control? he explains. And mushrooms might be able to do all of those things.

Its also increasingly common to see the digestible variety in unexpected forms, such as mushroom lattes on the menus at wellness-minded cafs and coffee shops. At Two Hands in New Yorks Tribeca, a drink containing a reishi mushroom powder by Wylde One is listed right alongside turmeric lattes and matcha teas. As Wylde One founder Stephanie Park notes, mushrooms are more closely related to humans than they are to plants, making their active compounds bioavailable to the human body. We share almost 50 percent of the same DNA with mushrooms, she says. For several thousand years, humans have had a deep connection to mushrooms, relying on them for their nutritional, medicinal and even spiritual powers. And now their beauty ones, too.

Here is the original post:
Forget CBD. Mushrooms Are the Beauty and Wellness Superfood You Need Right Now - Robb Report

Philippe Starck Is Living the Future – Mansion Global

Its difficult to describe Philippe Starck in a few wordsor even a few sentences. The French designer, whos known globally for his work in interior, exterior, product, furniture, industrial, and architectural design, has designed everything from low-energy wooden prefabricated houses (known as P.A.T.H., or Prefabricated Accessible Technological Homes), to yachts and hotels, to the residences of the French president.

Hes also responsible for one of the worlds most iconic pieces of furniturethe ghost chair.

Mr. Starck, 71, has coined the phrase democratic design, describing it as something that provides quality pieces at accessible prices.

More: Aspen Brokerage Founder Says Its Core Area is Expanding

And early this year, he announced his newest furniture collection, Oh, It Rains!, in collaboration with B&B Italia Outdoor, a company that focuses on functional furniture. The sofas and armchairs in the collection include a mechanical joint that allows the backrest to recline, as well as to fold over the cushions in order to protect the furniture in case of rain. The pieces are made of water-repellant proprietary textiles.

Outside of furniture and home design, Mr. Starck also had a brief stint as art director for the Virgin Galactic spaceport, is a winemaker (with his own Champagne with Maison Louis Roederer), makes perfume under the label STARCK Paris (interestingly, his mother operated a parfumerie when he was a child), and creates ultraflexible eyeglasses in collaboration with Luxottica, a project that combines design with biomechanics.

We caught up with Mr. Starck to discuss his passions, his inspirations, and what he felt was missing from outdoor furniture.

From Penta: Worldwise: Chef Nina Comptons Favorite Things

Mansion Global: Who are some of your inspirations in the design world?

Philippe Starck: I have no admiration for designers, architects, or artists. I love scientists. My heroes are Ptolemy, Einstein, Archimedes, et cetera. They are among the ones who change the world.

What does democratic design mean to you now? Has that changed throughout the years?

Im not really proud of what I do because design is useless. It can help improve lives, but it does not save lives. However, Im proud of my battle to democratize design: increasing quality, yet lowering prices in order to make design affordable for the wider public. Now that this battle is won, I can continue with democratic ecology and democratic architecture. I started with P.A.T.H., highly technological and high-quality prefabricated houses, to save energy, time, money, and guarantee longevity at the right price. Recently, I worked on the next commercial International Space Station in collaboration with Axiom to develop commercial space tourism. Im very happy to take part in this project because companies like Axiom are focusing on space research and are searching for solutions in order to democratize space.

How did the project with B&B Italia come about? What was your design inspiration for that collaboration?

I always say that to make beautiful children, parents have to be in love. Its the same with projects; to make beautiful projects, you have to share the same values with your partner. I always thought there was something wrong with outdoor furniture collections. When you are in a beautiful hotel, enjoying the swimming pool, and suddenly someone says: Oh, it rains! and hundreds of waiters start panicking, picking up all the pillows and cushions, there is something not quite right. So I wanted to create a solution. I worked on a whole range of options that allow you to intervene in a few simple steps when it starts to rain. For example, by simply folding the backrest forward, you can cover the upholstery like a protective flap, and as soon as the sun comes back, simply unfold and youre ready. This is the most elegant design made with high technology, high quality, and high intelligence.

More: Barrier-Breaking Architect Says Its Time for More Women in the Field

What will the furniture of the future look like?

Design is a simple tool that has been created to improve the ugly obligations of our daily life. There is no future for design, as we are now entering the era of bionism [the art of taking inspiration from the body to create technologies better suited to the human being, according to Mr. Starck] and dematerialization. In the coming years, all the useless things around us will disappear, they will become integrated directly into the walls, to the body. The next designer will be our coach, our dietician.

Youve also launched perfume. How do you get inspired to come up with scents? And what interests you about being in that business?

STARCK Paris is not a design project. It is a personal project, coming from my brain, from my heart. ...With my wife, Jasmine, we spent years discovering the works of almost all existing master perfumers,

carrying out blind tests. And eventually we recognized Daphn Bugey, Annick Mnardo, and Dominique Ropion as part of my sentimental tribe. People who share a vision and creative intelligence. We invented a new diagonal language in order to translate my vision, my mental space, actually turning my words into chemicals and perfumes. I am passionate about perfume because it is so powerful, abstractlike a vehicle, a weapon. With a nanodrop of scent, that is less than a milligram of liquid, you can create your own universe, your own territory.

Whats next for you?

To continue to direct my creation and my production toward immateriality, toward the minimum while giving the maximum. My Starck Biotech Paris glasses are a good example. We continue to explore biotechnology, while working on dematerialization and bionism by proposing new, innovative solutions. ... stay tuned.

This story first appearedin Mansion Global magazine, published on March 14th, 2020.

Click to Read More Luxury Real Estate Professionals Share Their Insights

Read the original:
Philippe Starck Is Living the Future - Mansion Global